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Nothing in life is to be feared, it is only to be understood.  
Now is the time to understand more, so that we may fear less. 
― Marie Curie 
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Abstract 
 
The thesis aims to explore the relationship between stress and immune response in poultry, 
focusing on acute phase proteins (APPs) and microRNAs (miRNAs) as welfare biomarkers for 
transport- and disease-related stress. We worked on two poultry species, namely turkey and 
chicken. Turkey (Meleagris gallopavo) was studied in order to provide new information in this 
species, which is poorly characterised for what concerns immunity and welfare. Existing studies 
related with avian species are mostly carried out on chicken (Gallus gallus), but there is still 
lacking information that needs to be addressed. In fact, we have complemented information, 
already available in chicken, describing the extrahepatic expression of APPs. 
The effects of transport-related stress on liver and adipose tissue gene expression of four APPs, 
namely α1-acid glycoprotein (AGP), Serum Amyloid A (SAA), PIT54 (Haptoglobin-like) and C-
Reactive Protein (CRP) was investigated. The expression of AGP and CRP mRNA was found to 
be increased in liver and adipose tissue from birds after road transport. The presence of AGP 
protein was also confirmed. In addition, the expression of the same APPs was studied under a 
disease-related stress, caused by a heamorrhagic enteritis virus (HEV), which is a stressful 
disease for turkeys. As preliminary results, the expression of AGP, PIT54 and SAA mRNA was 
found to be increased in liver and adipose tissue from HEV-affected birds, while CRP expression 
was decreased in jejunum from HEV-infected birds. These results showed that road transport and 
HEV disease induce the mRNA expression of AGP, PIT54, SAA and CRP, suggesting their use 
as welfare biomarkers in turkey species. Although APPs are produced mainly by liver, 
extrahepatic production has been described in many species but not in poultry. The expression 
and location of five APPs, namely AGP, SAA, PIT54, CRP and OVT, was studied in 20 
different tissues from healthy chickens. SAA, OVT and CRP mRNA expression was particularly 
higher in gastrointestinal tract, respiratory system and lymphatic system. AGP and OVT proteins 
were detected in different organs. Moreover, the expression of five miRNAs, namely miR-22, 
miR-155-5p, miR-181a-3p, miR-204 and miR-365-3p, was analyzed under transport-related 
stress in turkeys. The expression levels of miR-22, miR-155 and miR-365 were increased, 
suggesting they can be used to discriminate stressed- and unstressed animals. In order to better 
characterize the disease and to investigate a possible source of biomarkers, the intestinal 
proteome of turkeys was also determined to study the effects of HEV disease on intestinal 
mucosa. A total of 523 proteins were identified by SWATH-MS strategy between healthy and 
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HEV-affected birds. A number of 64 of them were found to be differentially expressed. The 
effective presence of fifteen proteins related with immune system was also validated by mRNA 
expression. These findings can help us to better understand the effect of HEV in turkeys. 
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Riassunto 
 
La tesi si propone di esplorare il rapporto tra stress e risposta immunitaria nel pollame, 
concentrandosi su proteine di fase acuta (APPs) e microRNA (miRNAs) come biomarcatori per 
il transporto e le malattie correlate a stress. Abbiamo lavorato su due specie di pollame, tacchino 
e pollo. Il tacchino (Meleagris gallopavo) è stato studiato in modo da fornire nuove informazioni 
in merito a questa specie, che è scarsamente caratterizza per quanto riguarda l'immunità e il 
benessere. Gli studi esistenti relativi alle specie aviarie sono stati effettuati sul pollo (Gallus 
gallus) e per completare le informazioni disponibili in letteratura, abbiamo descritto l'espressione 
extraepatica delle APPs in questa specie. 
Sono stati indagati gli effetti dello stress correlati al trasporto, studiando l’espressione genica di 
quattro APPs nel fegato e nel tessuto adiposo: α1-acid glycoprotein (AGP), Serum Amyloid A 
(SAA), PIT54 (Haptoglobin-like) and C-Reactive Protein (CRP). L'espressione di mRNA di 
AGP e CRP è risultata essere aumentata nel fegato e nel tessuto adiposo degli uccelli dopo il 
trasporto su strada. È stata confermata la presenza della proteina AGP. Inoltre, l'espressione delle 
stesse APPs è stata studiata anche nella patologia causata dal virus della enterite emorragica 
(HEV) e associata allo stress. Come risultati preliminari, l'espressione di mRNA di AGP, PIT54 
e SAA era aumentata nel fegato e nel tessuto adiposo di uccelli HEV positivi; al contrario, 
l'espressione di CRP era ridotta nel digiuno di uccelli HEV-positivi. Questi risultati hanno 
dimostrato che il trasporto su strada e la malattia HEV inducono l'espressione di mRNA di AGP, 
PIT54, SAA e CRP, suggerendo il loro uso come biomarcatori del welfare nel tacchino. Sebbene 
le APPs siano prodotte principalmente dal fegato, la produzione extraepatica è stata descritta in 
molte specie, ma non nel pollame. L'espressione e la localizzazione delle cinque APPs (AGP, 
SAA, PIT54, CRP e OVT) è stata studiata in 20 diversi tessuti di polli sani. L’espressione di 
mRNA di SAA, OVT e CRP era particolarmente elevata nel tratto gastrointestinale, nelle vie 
respiratorie e nel sistema linfatico. Le proteine AGP e OVT sono state trovate in diversi organi. 
Inoltre, l'espressione di cinque miRNAs (miR-22, miR-155-5p, miR-181a-3p, miR-204 e miR-
365-3p) è stata studiata nei tacchini in condizioni di stress legate al trasporto. Il livelli di 
espressione di miR-22, miR-155 e miR-365 erano aumentati, suggerendo il loro utilizzo per 
discriminare animali stressati e non stressati. Per caratterizzare meglio la malattia e individuare 
una possibile fonte di biomarcatori, è stato determinato anche il proteoma intestinale dei tacchini 
per studiare gli effetti della malattia HEV sulla mucosa intestinale. Sono state identificate 523 
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proteine utilizzando la strategia di SWATH-MS confrontando tacchini sani e malati e 64 proteine 
sono risultate essere differenzialmente espresse. È stata quindi validata l’espressione genica di 
quindici proteine correlate con il sistema immunitario. Questi risultati possono aiutare a 
comprendere meglio l'effetto di HEV nei tacchini. 
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PhD thesis rationale 
 
The main aim of this thesis is to identify biomarkers to evaluate animal welfare and food quality 
in poultry species. A fundamental issue of farm animal welfare is to keep animals clinically 
healthy, without diseases or stress, in order to produce safe and high quality food. This topic is 
highly relevant for both Governments and food industries worldwide, being directly linked to 
public health and animal well-being. 
It is known that domestic farm animals, in modern production, have to deal with several stressors 
during their life such as weighting, vaccination and a lot of environmental and management 
procedures such as road transport. These factors can affect the behavioural, physiological and 
performance responses of animals. Road transport has been identified as one of the most stressful 
events for animals, especially for poultry. The task of monitoring animals’ welfare is 
challenging. Reliable biomarkers, with few exceptions, are virtually absent, and most of the 
measurements to assess animal welfare still rely on animal behaviours features. The potential use 
of molecular biomarkers seems to be a good way to control if the animals are healthy and ensure 
their welfare. 
The expression of acute phase proteins (APPs) has been shown to depend on inflammatory status 
but also on different diets and stress levels, in different domestic species. APPs belong to a large 
family of structurally unrelated proteins that are produced as part of the systemic inflammatory 
response and play a role in modulating innate immunity and scavenging inflammatory by-
products. Although APPs are produced mainly in liver, they can be synthesized also in other 
tissues. APP are commonly used to monitor welfare in animals. 
MicroRNAs (miRNAs) have also been identified in humans as biomarkers for a high number of 
diseases and biological processes. Research in animal science is lagging behind. The modulation 
of miRNAs expression is also an early event in stressful conditions. MiRNAs are small 
regulatory non-coding RNAs that modulate gene expression and play key roles in immune 
defenses and inflammation. Moreover, miRNAs are non-invasive biomarkers and can be easily 
extracted from extracellular body fluids. 
In the last years, many knowledge has emerged in farm animals, but not in all the species (e.g. 
turkey). Although turkey (Meleagris gallopavo) farming is economically relevant, no 
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information regarding APPs is available, as compared with other poultry species, and there is 
very limited information on the welfare of turkeys during transport. From a clinical perspective, 
the use of APPs as biomarkers for stress in poultry has not been adequately addressed so far. The 
identification of suitable biomarkers of stress and disease is of paramount importance, with the 
final aim to reduce as much as possible the stress level in animals. Moreover, the APP 
expression in poultry is usually linked to a pathological status and a widespread expression study 
has never been done so far. 
In this study, we focused on two models of stress: the stress related to management (e.g. stress 
due to transport) and the stress related to disease (e.g. the stress due to an extremely stressful 
disease in turkeys, namely viral heamorrhagic enteritis). 
We also integrated the state of art of the knowledge about APPs in poultry with new information, 
derived from APP expression in a model of stress due to transport and characterization of local 
APP production in healthy chicken tissues, to assess where APP are produced and their tissue 
expression amount. The major APPs in turkey during transport were identified and their potential 
use as indicators of transport-related stress was investigated. As a preliminary study, the mRNA 
expression of APPs in a model of disease due to heamorrhagic enteritis virus infection was also 
investigated in turkeys. The potential use of microRNA as welfare biomarkers in a similar 
transport model was assessed. Some miRNAs related with stressful events and immune response 
were evaluated as non-invasive markers of transport stress.  
In the first part of the thesis, extrahepatic expression of five APPs – AGP, SAA, PIT54, CRP and 
OVT, was studied in a large panel of 20 chicken tissues. Avian acute phase response and APP 
studies only focus on inflammation and liver is considered the major source of APP, although 
extrahepatic expression has been described before for other animal species. We tried to 
understand how much the other tissues could contribute for the innate and adaptive immunity by 
producing APPs in healthy conditions. Immunolocalization was also identified using available 
antibodies. Results of this study are reported in Chapter 5.1. 
In the second part of the thesis, four APPs, previously found to be overexpressed in chicken – 
AGP, SAA, PIT54 and CRP, were investigated under a model of transport-related stress in 
turkeys, in order to determine whether mRNA expression in liver and adipose tissue was 
increased after a stressful condition. Immunolocalization was also identified using available 
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antibodies. In the case of absence of antibodies, we tried to produce them. In particular, the 
expression of the already known biomarkers, such as APPs, is presented in Chaper 5.2. 
In the third part of the thesis, innovative biomarkers (miRNAs) were studied under a model of 
transport-related stress in turkeys, in order to determine if they can be considered as welfare 
biomarkers. The serum levels of five miRNAs – miR-22, miR-155, miR-181a, miR-204 and 
miR-365, were quantified in order to investigate whether transport-related stress modifies the 
expression of circulating miRNAs and if there is a potential scope in their use as welfare 
biomarkers. The expression of the novel biomarkers (miRNAs) is presented in Chaper 5.3. 
In the fourth part of the thesis, the intestinal proteome of turkey was characterized. 
Gastrointestinal (GI) tract is regarded as one essential organ for nutrient absorption, pathogen 
prevention and immune response in poultry. Virus infections of the GI tract occur regularly in 
poultry and impacts negatively the bird welfare. However, no information about turkey intestine 
proteome is available. The proteome from healthy and haemorrhagic enteritis (HE) virus-
infected animals was then determined, focusing again on the local expression of APPs rather 
then the systemic one. Haemorrhagic enteritis was identified as a model for disease because it 
affects particularly turkeys, and it is geographically widespread and endemic in many areas. 
Turkey intestine proteome is described in Chapter 5.4. 
In the fifth part of the thesis, four APPs – AGP, SAA, PIT54 and CRP, were investigated under a 
model of HE virus infection in turkeys, in order to determine whether mRNA expression in liver, 
adipose tissue and small intestine (jejunum) was increased in sick birds. Preliminary results are 
presented in Chaper 5.5.  
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Chapter 1. Welfare, stress and road transport 
 
1.1. Animal welfare 
Welfare is not only the absence of cruelty and suffering. It is a multidimensional concept that 
embraces three animals’ states: physical, mental and natural state (Figure 1), as well as high 
levels of biological perfomance and the potential for animals to have positive experience (Fraser 
et al., 1997). 
Physical state 
McGlone (1993) stated that welfare is poor when physiological systems are disturbed to the 
point that survival and/or reproduction is impaired. High mortality rates are indicative of poor 
welfare. Instead, Broom (1986) have referred to how an animal can cope with its environment. 
Coping is an essentially reflection of the physical condition, although nowadays mental states are 
known to contribute to this circumstance. Physical state envisages that the animals are healthy, 
have high levels of biological performance, successful reproduction rates and can cope with the 
environment. 
Mental state 
Mental states is one of the central points in welfare. They are more difficult to understand and 
are becoming more investigated and explored, especially by scientists. Welfare is strongly 
related to what the animal feels and fears, even more than health, lack of stress or fitness 
(Duncan, 1993). Well-being of the animals also involves their capability to have positive 
experiences and various forms of pleasure (Broom, 1998). 
Natural state 
Natural state refers to the ability of the animal to fulfil its natural needs and desires. Not being 
able to cope with its natural needs, the animal feels frustrated and this harms its welfare. Welfare 
means not only control of pain and suffering, but also considers the fulfilment of the animals’ 
nature (Rollin, 1993). 
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Figure 1. Welfare framework. Three animals’ states (physical, mental and natural state) are referred 
together to describe the welfare concept. 
 
Given this background, the definition of animal welfare is often debated. Welfare concerns the 
quality of an animals’ life and not only how long the life lasts (quality versus quantity). The 
knowledge about the needs of animals has proposed to give animals’ defined “freedoms”. The 
“Five Freedoms”, which were originally developed by the UK Farm Animal Welfare Council 
(FAWC, 1993), are often used as a framework to assess welfare, providing valuable guidance on 
animal well-being. 
The “Five Freedoms” are: 
• Freedom from hunger and thirst – access to water and a correct diet to maintain health 
and vigour; 
• Freedom from discomfort – appropriate environment, including shelter and a comfortable 
resting area; 
• Freedom from pain, injury and disease – prevention for diseases or rapid diagnosis and 
treatment; 
• Freedom to express normal behaviour – sufficient space, proper facilities and company of 
their own species; 
• Freedom from fear and stress – proper handling conditions and treatment to avoid mental 
stress. 
The current importance of animal welfare is not only focused on ethics and the belief that 
animals can suffer, but it has also received a major consideration in meat quality and quantity 
Welfare
Mental (feelings)
Physical (fitness)
Natural (needs)
Tumours, infections, 
diseases
Fear, anxiety
Restrict natural 
behaviour
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(Gispert et al., 2000; Schwartzkopf-Genswein et al., 2012; Terlouw et al., 2008). Healthy and 
happy animals will provide better animal derived food for humans. 
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1.2. What is Stress? 
Stress occurs when the organism perceives a threat of disruption of homeostasis, although it is an 
abstract internal state without any clear definition. Stress is a part of life and all organisms have 
evolved mechanisms to cope with it. When applied to animal production, stress usually indicates 
a real or perceived perturbation that adversely affects homeostasis or welfare. Two types of 
stress shall be differentiated. The animal can develop a non-threatening stress response (often 
referred to as “good stress”) or the stress response truly threatens the biological state and has a 
negative effect on the animals’ welfare (referred to as “bad stress” or distress) (NRC, 2008). For 
this thesis, the term stress will be used in general to refer to a negative experience for the 
animals’ homeostasis. 
Stressors are events or threads that can activate any mechanisms or adaptive responses, including 
behavioural reactions, activation of the hypothalamic-pituitary-adrenal (HPA) axis and adrenal 
gland, activation of the sympathetic branch of the autonomic nervous system (ANS), secretion of 
stress hormones (e.g. glucocorticoids), and/or mobilization of the immune system (Minton, 
1994). Although a stress response is involved in, at least, one of the above systems, none of them 
are exclusive to identify a stressful state (Moberg, 2000; Schneiderman et al., 2005). 
Physiological and behavioural reactions to stress are dependent from the original stressor and it 
is well established that different animal species and even animals of the same species but 
different genetic background responds differently to the same stressor to restore its own 
homeostasis (Hall et al., 1998). 
The following list includes some considered stressors: 
• Viral or bacterial infections; 
• Threat of physical harm; 
• Drugs; 
• Noises; 
• Dark places; 
• Climatic changes (intensive cold or heat); 
• Restraint; 
• Food and water deprivation; 
• Pre-mixing and no-familiar social interactions; 
• Road transport. 
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In a response to stress, the body activates behavioural or physiological mechanisms to counter 
this perturbation and return to its homeostasis. The animal may not always manifest stress with 
recognizable evident behaviours but, instead, with subclinical pathological changes, sometimes 
imperceptible. 
Moberg (1985) has divided response of animals’ stress into three general stages: the recognition 
of a stressor, the biological defense against the stressor and the consequences of the stress 
response. Fear and pain are very strong and common causes of stress in livestock and, when 
suffering from severe stress, animals can develop diseases, fail to reproduce and/or stop to grow 
up properly. Thus, the condition of a stressed animal is considered atypical and regarded as 
undesirable (Stott, 1981). 
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1.3. Biological basis of stress 
A stress response begins with the central nervous system (CNS) perceiving a stressor that can be 
positive or negative (Moberg, 2000). The CNS controls the action of endocrine glands through 
the release of neurotransmitters (e.g. catecholamines and indoleamines). Specific brain areas are 
recognized to be involved in the stress response organization. Amygdala, hippocampus and 
prefrontal cortex are connected with hypothalamus, which modulates the final stress response 
through activation of HPA and the sympathetic nervous system (SNS) (Mora et al., 2012). Once 
the CNS perceives a threat, it develops a biological response that consists of combination of the 
four general biological defense responses (Figure 2):  
• behavioural response; 
• autonomic nervous system response; 
• neuroendocrine response; 
• immune response. 
 
 
Figure 2. A model of the biological response of animal to stress. Adapted from Moberg (2000). 
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The HPA axis, often referred to as the “stress response system”, is one of the primary endocrine 
system that reacts to stressors (Chrousos, 2000; Moberg, 2000). In response to a stressful 
situation, the hypothalamus synthesizes corticotrophin-releasing hormone (CRH) and arginine 
vasopressin (AVP), which travel to the anterior pituitary and cause the release of 
adrenocorticotropic hormone (ACTH) into the circulatory system. AVP is considered the second 
most important modulator of pituitary ACTH secretion (Antoni, 1993). ACTH acts selectively 
on specific receptors in the adrenal cortex, resulting in the release of steroids by promoting the 
uptake of cholesterol and its enzymatic conversion to glucocorticoids (cortisol and 
corticosterone) (Figure 3). In turn, corticosteroids mobilize energy stores in response to the 
perceived stress and affects a diverse number of biological systems, including the cardiovascular 
system, gastrointestinal system, exocrine glands and adrenal medulla (Uchoa et al., 2014). 
Cortisol is the primary glucocorticoid in humans and most mammals, whereas corticosterone is 
the primary glucocorticoid in the rodents. Glucocorticoids play an important role in 
gluconeogenesis by stimulating the conversion of glycogen into glucose for energy, and by 
promoting lipolysis to break fats into usable sources of energy (Brindley and Rollan, 1989). 
Glucocorticoids also support the stress response by potentiating the synthesis and action of 
catecholamines released by the adrenal medulla. 
When the stressor is removed, glucocorticoids bound to receptors in the hypothalamus and 
anterior pituitary initiate negative feedback that causes a decrease in the production and release 
of CRH and ACTH, thus terminating the hormonal response and completing the negative 
feedback loop (Keller-Wood, 2015). 
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Figure 3. Schematic diagram of the major components of the hypothalamic–pituitary–adrenal (HPA) 
axis. Adapted from BGD Lecture-Endocrine Histology available at https://embryology.med.unsw.edu.au. 
 
Stressors can also activate the sympathetic division of the ANS (Chrousos, 2000; Moberg, 2000). 
This system is the basis of Cannon’s proposed “flight-or-fight” response during stress (Cannon, 
1929). The “flight-or-fight” response (also called acute stress response) is a physiological 
reaction that occurs in response to a perceived harmful event. Animals react to threats with a 
general discharge of the SNS, preparing for fighting or fleeing (Figure 4). 
Adrenal medulla is part of the sympathetic division of the ANS, working as an endocrine organ 
and playing a role in the overall regulation of the HPA axis at several levels, including the brain 
and the pituitary gland. Activation of the sympathetic pathway initiates release of a hormonal 
cascade from the adrenal medulla that results in the secretion of catecholamines (e.g. epinephrine 
or adrenaline and norepinephrine or noradrenaline), which act on various target organs and 
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and awareness, adrenaline and the indolamine serotonin seems to be associated more with 
anxiety and fear (Abelson et al., 1996; Arroyo et al., 2016; Fell et al., 1985).  
This activation leads to increased heart rate, blood pressure, breathing, increased mobilization of 
nutrients, and redistribution of blood flow (Blanc et al., 1991). Some stressors may also increase 
the activity of the parasympathetic division, affecting both core body temperature and the 
gastrointestinal system (Goldstein, 2013). However, because the autonomic responses affect very 
specific biological systems and its effects are of relatively short duration, ANS does not have a 
significant impact on an animals’ long-term welfare. 
 
 
Figure 4. Schematic diagram of the major components of the sympathetic division of the autonomic 
nervous system (ANS). 
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Signalling pathways link the brain with the immune system, combining the HPA axis and the 
immune system activation (Dhabhar, 2009; Nance and Sanders, 2007). During stress, 
lymphocytes and macrophages are activated and express receptors for a variety of hormones and 
neurotransmitters, while the spleen and thymus are innervated by the ANS (O’Connor et al., 
2003; ThyagaRajan and Priyanka, 2012). Cytokines and other humoral mediators of 
inflammation have also been demonstrated to act as potent activators of the central stress 
response. Three main inflammatory cytokines – tumor necrosis factor-alpha (TNF-α), 
interleukin-1 (IL-1) and interleukin-6 (IL-6) – are able to enhance the synthesis and secretion of 
CRH and AVP at the level of the hypothalamus (Bernardini et al., 1990; Naitoh et al., 1988), 
whereas ACTH secretion have direct effects on glucocorticoids secretion (Figure 5) (Fukata et 
al., 1989; Salas et al., 1990).  
Adaptive immune responses, that involve antigen recognition by T cells, have been shown to be 
invariably affected during acute stress (Fleshner et al., 1995). 
 
 
Figure 5. A simplified schematic representation of the interactions between the HPA axis and the 
immune system. Solid lines represent stimulatory effects and dashed lines represent inhibitory effects. 
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cytokine resistance and inhibit the expression of receptors on the surface of immune cells 
(Chrousos, 1995). Glucocorticoids and catecholamines secreted during stress exert an 
immunomodulative effect by suppressing the T-helper response, thus protecting the tissues from 
the potentially destructive actions of immune system (Elenkov et al., 1999). 
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1.4. Welfare and road transport 
Road transport is a necessary practice that livestock encounters during their lifetime. Animals 
need to be transported for various reasons – for feeding and growth, harvest and breeding 
purposes, re-stocking or before slaughtering process (Broom, 2005; Schwartzkopf-Genswein et 
al., 2012). 
Road transport is a complex procedure including: 
• assembly and loading of animals at their place of origin;  
• confinement on a moving or stationary vehicle, sometimes without food, water and rest; 
• unloading and lairage at their final destination. 
The protection of animals at the time of transport is covered in European Union (EU) by the 
Council Regulation (EC) No 1/2005 of 22 December 2004. The document information can be 
found at (http://eur-lex.europa.eu/legal-content/en/TXT/?uri=CELEX:32005R0001). It relates to 
protecting the animals’ welfare during transportation to prevent injuries or unnecessary 
suffering, and applies to the transport of live vertebrate animals carried out within the EU. When 
animals are subjected to unusual conditions or circumstances, the welfare of these animals 
should be taken in account for them to avoid suffering unnecessary discomfort, stress or injuries. 
Among the general conditions of transportation, it is recomended that: 
• The animals should be adequately prepared for the transport; 
• The handling of animals should be carried out by trained and competent people; 
• Any methods such as violence, fear, injuries or suffering should be avoid; 
• The animals should have access to water, feed and appropriate rest at suitable intervals; 
• Transportation to the destination must involve regular checks on the welfare. 
The regulation also gives stricter rules for longer journeys and efficient checks at the point of 
departure and on a random basis thereafter. 
If a good welfare associated with the transport of animals is guaranteed, the mortality rates and 
carcass downgrading are reduced and the financial income increases. In addition, if the general 
public starts to be aware of animals’ welfare concerns during transport, they will take it in 
account when deciding whether or not to purchase animal products. 
30 
 
The properties of meat that are of major interest to the consumer (e.g. tenderness, juiciness and 
flavour) are strongly affected by pre-treatments before slaughter. Animals often experience 
physical and physiological insults when they are transported and handled, decreasing welfare and 
meanwhile reducing carcass yield and meat quality. Weschenfelder et al. (2012) has published a 
study evaluating the effects of road transportat practices in pig on animal behaviour, 
physiological parameters as welfare markers, carcass and meat quality. 
In cattle, “bad welfare” lowers the glycogen meat content and consequently elevates pH 
(Lahucky et al., 1998). Glycogen is required as energy for muscle activity in the animals. In a 
healthy and non-stressed animal, the glycogen content of the muscle is high. After the animal has 
been slaughtered, the glycogen in the muscle is converted into lactic acid and the carcass 
becomes firm. If the animal is stressed before or during slaughter procedures, the glycogen is 
depleted due to the increase need of energy and the lactic acid level that develops in the meat 
decreases (Lambert et al., 1998). This will have serious adverse effects on meat quality, since the 
lactic acid has the effect of retarding the growth of bacteria and contributes to meat properties, 
such as color, taste and tenderness. 
 
1.4.1. Road transport as stress model 
Road transportation for short or long periods can impose stress to animals. Stress responses have 
been demonstrated in different animal species by, for example, increases in heart rate (Kent and 
Ewbank, 1986), increased adrenal cortical activity (Ruiz-de-la-Torre et al., 2001), decreased 
humoral immunity (Machenzie et al., 1997) and increased morbidity and mortality due to 
infectious diseases in the few weeks following transportation (Chirase et al., 2004; Hartung, 
2003). 
Road transportation had been demonstrated to be a stressful event prior to slaughter for: 
• cattle (Grigor et al., 2004; Schwartzkopf-Genswein et al., 2012); 
• bulls (Earley et al., 2013);  
• pigs (Piñeiro et al., 2007; Salamano et al., 2008; Schwartzkopf-Genswein et al., 2012); 
• poultry (Schwartzkopf-Genswein et al., 2012). 
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This kind of stress situation may impose to animals both physical and emotional effects in 
varying degree. An animal may experience emotional stress during transport followed by 
physical stress (Tarrant, 1990; Tarrant et al., 1992). 
Turkey species makes no exception and road transportation is also regarded as one of the most 
stressful event in the turkeys’ lifetime as well (Marchewka et al., 2013), reflecting direct effects 
on economical losses due to injuries and/or the increased death on arrival (DOA) rate (Petracci et 
al., 2006). In fact, most of the studies on the impact of road transport on poultry addressed its 
effect on the carcass quality, conversion of muscle, meat color, texture, and related negative 
effects on processed products (Schwartzkopf-Genswein et al., 2012). 
Intensive rearing of the birds at geographically dispersed sites requires transport by road to 
centralized processing facilities to slaughter. The birds may be exposed to a variety of potential 
stressors during transit, including the thermal demands of the transport microenvironment, 
acceleration, vibration, motion, impacts, fasting, social disruption and noise (Mitchell and 
Kettlewell, 1998). The adverse effects may range from mild discomfort and aversion to death. 
Responses of birds to transportation involve many factors such as health status before 
transportation, how the birds are handled, loaded and unloaded, truck design, loading density, 
environmental condition, transit duration, lairage duration, and length of feed withdrawal 
(Schwartzkopf-Genswein et al., 2012). Studies carried by Bayliss and Hinton (1990) described 
that 40% of DOA during pre-slaughter are due to the poultry transport to the abattoir. Beside this 
economical perspective, there is also an ethical aspect that has to be addressed. The identification 
of suitable biomarkers of stress is of paramount importance in order to develop handling and 
transport procedures that minimize the stress level in animals. 
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1.5. Welfare and diseases 
Diseases can spread rapidly among poultry because they are usually kept together in a cage or in 
overcrowded areas. They also share the same food and water bowls. In this farming status, 
diseases provide to animals heavy disturbance of welfare. 
There are four main types of diseases affecting poultry, which are briefly listed hereby:  
• metabolic and nutritional diseases;  
• behavioural diseases; 
• parasitic diseases; 
• infectious diseases. 
Metabolic and nutritional diseases 
In poultry, these are conditions associated with a disturbance of normal metabolic functions 
either through a genetic defect, inadequate or inappropriate nutrition, such as increased 
metabolism, rapid growth rate or high egg production. These include Fatty Liver, Kidney 
Syndrome, Perosis, Rickets, Layer Fatigue and various cardiovascular diseases and metabolic 
disorders associated with egg production (Julian, 2005). 
Behavioural diseases 
Abnormal behavioural patterns can lead to injury or even ill health of the birds. These include 
fightings, aggressive pecking, or even cannibalism (Dennis et al., 2004; Lay et al., 2011). 
Parasitic diseases 
Parasitic diseases are often contracted through contact with an intermediate vector, but may 
occur as the result of direct exposure. The prevalence of most parasitic diseases in poultry 
contribute significantly to the low productivity (Permin and Hanson, 1998). The most frequent 
parasitic diseases include Coccidiosis, Cryptosporidiosis, Histomoniasis, Parasitic Worms (or 
Helminths), Toxoplasmosis and Trichomoniasis. 
Infectious diseases 
Infectious diseases can be spread directly or indirectly from one bird to another. These include 
Marek's disease, Infectious bronchitis, Infectious bursal disease, Newcastle disease, Fowlpox, 
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Avian encephalomyelitis, Chicken infectious anemia, Salmonellosis, Colibacillosis, 
Mycoplasmosis, Avian influenza, Avian tuberculosis, Chlamydiosis, Fowl cholera, 
Pasteurelloses, Infectious laryngotracheitis and Haemorrhagic enteritis (Brioudes et al., 2014; 
Miller et al., 2013; Saif, 1998). 
 
1.5.1. Haemorrhagic enteritis virus as disease model to measure welfare 
Virus infection of the gastrointestinal tract regularly occur in poultry. Many pathogens establish 
contact at intestinal mucosa surface. In field, these infections are always complicated by other 
infectious agents and, due to mucosa damage, leads to malnutrition, weight loss and death of the 
birds. Enteritis in poultry provide a very good model for health-related welfare disturbance. 
Haemorrhagic enteritis (HE) is an acute gastrointestinal (GI) disorder affecting young turkeys at 
4–5 weeks old, and can compromise the commercial production of livestock. The etiologic agent 
is the haemorrhagic enteritis virus (HEV), a member of the family Adenoviridae, type II, a non-
enveloped, icosahedral DNA virus and 70–90 nm in diameter (Guy, 1998). Although HEV has 
been recognised since 1937 (Pomeroy and Fenstermacher, 1937), the mechanisms of viral 
immunopathogenesis and immunosuppression are still under study. Chickens are also susceptible 
to HEV but the greater severity of this disease occurs in turkeys (Rautenschlein et al., 1998).  
HEV is geographically widespread and considered endemic in areas where turkeys are raised 
commercially. The usual route of infection is oral, and virus is often introduced into previously 
uninfected birds by equipment contaminated with infectious feces. The virus can survive in feces 
for months and in litter for weeks. 
HE disease is characterized by acute onset of depression, pallor of mucosa, splenomegaly, 
diarrhea, intestinal haemorrhage and sudden death. The virulence of the virus varies but 
morbidity may approach 100%. Mortality can also be observed but it is rare because of extensive 
use of vaccines available. However, birds that survive experience a transient immunodepression 
and immunosuppression related to the lymphotrophic and lymphocytopathic nature of the virus. 
This often manifests itself in the form of HEV-related secondary infections with opportunistic 
pathogens agents such as the avian pathogenic Escherichia coli, bacterial respiratory diseases or 
septicemia (Koncicki et al., 2012). Prior exposition to Necrotic enteritis virus, Coccidiosis, 
Newcastle disease virus or Mycoplasma gallisepticum can exacerbate the problem, resulting in 
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mortality rates from 10–60% (Rautenschlein and Sharma, 2000). Usually, animals with less than 
4 weeks old are resistant to infection because of the presence of maternal antibody (Fadly and 
Nazerian, 1989). 
Following oral inoculation, HEV is detected in the intestine, bursa of Fabricius and caecal tonsils 
on day 1 day after infection. HEV replicates in these organs before entering the systemic 
circulation and migrating to the spleen. Inside the spleen, the virus reaches its peak levels of 
replication on day 4. The spleen is usually enlarged, friable and mottled white. Viral replication 
in B cells and macrophages induces necrosis and apoptosis of these cells, which leads to the 
depletion of IgM+ B cells and of functional macrophages. However, the spleen architecture 
returns to normal status on day 10 (Rautenschlein and Sharma, 2000; Saunders et al., 1993; 
Soback et al., 1985; Suresh and Sharma, 1995).  
Infected lymphocytes circulate through other organs but the organs remain anatomically intact. 
At day 5, haemorrhagic lesions and bleeding in the intestine start to occur. Very low levels of 
virus are detected in the intestinal tissue, even in the presence of intestinal lesions (Suresh and 
Sharma, 1996; Rautenschlein et al., 1998). The virus is detected in the lamina propria of the 
intestine but not in mucosal epithelial cells (Hussain et al., 1993). However, birds reveal 
congestion and occasional intraluminal haemorrhage in the small intestine. 
The role of T cells in HEV infection has not been elucidated in details. T cells are also attracted 
to the spleen and the relative percentage of CD4+ cells increase between days 4 and 6, while 
CD8+ levels are observed only at day 16 after infection (Suresh and Sharma, 1995). T cells also 
induce the production of various inflammatory cytokines (eg. TNF-α, IL-1β and IL-6). The 
production of these cytokines is massive, unregulated and leads to a systemic shock. Thus, it has 
been suggested that the HEV lesions and the degeneration of the intestinal epithelial cells is not 
due to the effects of the virus but, instead, a virally induced cytokine-mediated reaction, which 
leads to a haemorrhagic shock in the birds (Figure 6) (Suresh and Sharma, 1996).  
In endemic areas, turkey flocks are vaccinated by drinking water, using avirulent HEV strains, or 
marble spleen disease virus (MSDV), a closely related virus that is non-pathogenic for turkeys. 
Despite vaccination, outbreaks occurs in the field. Diagnosis of HEV is based on clinical signs 
and lesions, and PCR techniques to detect hemorrhagic enteritis viral DNA (Hess et al., 1999).  
We identified HEV as a model for stress during disease because the enteritis caused by the virus 
can have severe effects on the GI tract condition and negatively affect health and performance of 
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birds in commercial turkey flocks. Haemorrhagic enteric diseases are a major issue to the turkey 
industry, affecting loss of productivity, increasing mortality, and they are regarded as major treat 
over animal welfare. 
 
 
Figure 6. Model of haemorrhagic enteritis virus (HEV) immunopathogenesis. HEV replicates in B cells 
and macrophages. HEV induces apoptosis of B cell and macrophages, leading to immunosuppression. 
HEV induce T cells to produce cytokines, which activate macrophages. Activated macrophages secrete 
inflammatory cytokines that cause intestinal haemorrhage. Adapted from Rautenschlein et al. (2000). 
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1.6. Methods to assess stress 
 
Assessment of stress is different from species to species and husbandry conditions, as well as in 
each individual animal. To effectively evaluate stress, the collection of multiple behavioural and 
physiological parameters can be employed by various teams, including researchers, 
veterinarians, technicians and animals’caretakers. 
Behavioural parameters are often the most obvious indicator that an animal is having a difficult 
time to cope with a particular situation. The animal develops behaviours to avoid an unpleasant 
state. In addition, internal physiological indicators, such as changes in heart and respiratory rates, 
adrenal response and neurotransmitters will also increase or decrease. Physiological parameters 
are mediated through the endocrine, neural and immune system and can be quantified by the 
changes of stress hormone levels, including glucocorticoids, catecholamines, indolamines, 
growth hormone and prolactin. 
Methods to assess animals’ stress include: 
Behavioural observation: 
• feeding behaviour; 
• sexual behaviour;  
• maternal behaviour;  
• attention to threat; 
• unusual scratching. 
Physiological measures: 
• temperature change; 
• respiratory rate;  
• heart rate; 
• blood pressure; 
• body weight; 
• physiological parameters (e.g. glucocorticoids, catecholamines and indolamines). 
These methods are often used to assess animal welfare (Hill and Broom, 2009; Marchewka et al., 
2013; Piñeiro et al., 2007; Tuchscherer et al., 2014). 
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Given the direct association between stress and HPA axis, glucocorticoid levels can be used as 
indicators for the strength of a stressor and cortisol is the most frequently employed biomarker to 
assess the effect of several stressors in animals (Hart, 2012). Cortisol is typically measured in 
blood serum or plasma but can also be quantified in saliva, urine, feces and hair (Abelson et al., 
2005; Escribano et al., 2015; Kersey and Dehnhard, 2014; Meyer and Novak, 2012). 
Beyond the major hormones of the HPA axis, stressors stimulate the secretion of other endocrine 
factors (e.g. prolactin, growth hormone, luteinizing hormone, α-melanocyte stimulating hormone 
(α-MSH), and oxytocin). Serum levels of these hormones can be effectively used to monitor the 
temporal dynamics of stress responses (Ranabir and Reetu, 2011). Cholesterol and low density 
lipoprotein-associated cholesterol (LDL-cholesterol) were also identified as a stress marker in 
pigs housed at different stocking densities (Marco-Ramell et al., 2011), as well as serotonin and 
dopamine were involved in the pig’s response to handling at the slaughterhouse and to fear by 
tonic immobility (Arroyo et al., 2016). Serotonin has related to aggressiveness in chickens 
(Dennis et al., 2013). Blood metabolites were also assessed as oxidative stress markers in 
broilers exposed to higher temperature (Lin et al., 2006). In addition, various other biochemical 
parameters such as non-esterified fatty acids, triglycerides, cholesterol, urea, creatinine and fecal 
corticosterone were validated as indicators of stress in cows and pigs under housing and feed 
stress (Marco-Ramell et al., 2016; Saco et al., 2008). Because these compounds are also released 
in response to other stimuli, it is necessary to take into consideration and control normal patterns 
of secretion in order to accurately interpret their concentration levels. 
Although methods to assess stress are focused on identifying hormones and compounds levels 
outside of a “normal range”, there is no scientific standardized ranges for basal stress markers 
concentration. On the other hand, both positive and negative stimuli can activate the HPA axis, 
and hormonal changes are not necessarily present under all clearly stressful conditions (Bomholt 
et al. 2005; Ulrich-Lai et al. 2006). Most of these stress markers identified so far show a rapid 
response and their values quickly return to basal levels once the stressor disappears (Soler et al., 
2013), and their meaningful interpretation is subjected to limitations. 
In conclusion, the measurement of welfare is difficult and subjective. Although solid and 
standard welfare protocols exist for poultry, the Welfare Quality® (2009), Assessment Protocol 
for Poultry, reports that these protocols cannot be applied successfully to turkey species 
(http://www.welfarequalitynetwork.net/network/45848/7/0/40). 
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The knowledge of how welfare management tools, previously applied to other species, can be 
applied also to turkeys is unclear, and this prevents a correct quantification of the effects of 
management practices on turkey productivity and welfare. The standard protocols to assess 
animal welfare are often incomplete or unsuitable, since they differ in the thresholds set to 
differentiate high versus poor welfare, and/or in the way the information is integrated to form an 
overall evaluation judgment (Botreau et al., 2007). 
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Chapter 2. Acute phase proteins as welfare biomarkers 
 
2.1. Acute phase proteins (APPs) 
APPs are plasma proteins, mainly synthesized by hepatocytes, as part of the acute phase 
response (APR), and mediated by the major pro-inflammatory cytokines such as tumor necrosis 
factor-alpha (TNF-α), interleukin-1 beta (IL-1β) and interleukin-6 (IL-6), which are released 
during inflammation at the site of injury (Gabay and Kushner, 1999; Moshage, 1997; Schrödl et 
al., 2016). The APR is a core part of the innate immune response, which carry out an important 
role in the early defense mechanism and serves to initiate the acquired immune response to 
prevent infection, eliminate potential pathogens and initiate the inflammatory process (Figure 7). 
 
 
Figure 7. APPs secretion by the liver during healthy and injury condition. Liver is the main organ to 
contribute for circulating APP, protecting healthy state and preventing injury state.  
 
APP concentration can change significantly as a consequence of many health problems, which 
can be an inflammation caused by physical trauma, microbial infections, immunological 
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demonstrate “major”, “moderate” or “minor” responses depending on the magnitude of increase 
during the APR (Cray et al., 2009; Eckersall and Bell, 2010): 
 
• Major APP 
Major APP has a low serum concentration (< 1 g/L) in healthy animals, which rises dramatically 
by 10– to 1000–fold after stimulation, peaking at 24–48 h, and then declining rapidly during the 
recovery phase. 
• Moderate APP 
Moderate APP increases around 2– to 10–fold after activation, peaking after 2–3 days, and then 
decreasing more slowly than a major APP. 
• Minor APP 
Minor APP shows only a slight increase of slight 1– to 2–fold after activation. These APP are 
not considered as a marker during APR. 
• Negative APP 
Negative APP falls in concentration during the inflammatory response, such as albumin and 
transferrin.  
 
From a clinical perspective, APPs also provide useful biomarkers to detect the early onset of 
diseases or to assess welfare. APPs can be used in diagnosis, prognosis and in general health 
screening. As biomarkers of disease, they are highly sensitive indicators of inflammation, 
although lacking specificity. APP response also differs among species (Table 1). 
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Table 1. List of major and moderate APPs that respond to inflammatory stimuli in 
common farm animals. 
Species Major APPs Moderate APPs 
Pig MAP, SAA, CRP Hp 
Cow Hp, SAA AGP 
Goat Hp, SAA FB 
Sheep Hp, SAA AGP, CRP 
Rabbit Hp, SAA AGP, CRP, FB 
Chicken N/A AGP, SAA, PIT54, OVT 
Hp, haptoglobin; SAA, serum amyloid A; AGP, alpha 1-acid glycoprotein; CRP, C-reactive protein; MAP, major 
acute phase protein; PIT54, scavenger receptor cysteine-rich domain-containing protein LOC284297 homolog 
(haptoglobin-like); OVT, ovotransferrin; FB, fibrinogen. 
 
In swine, pig major acute phase protein (pig-MAP), serum amyloid A (SAA) and C-reactive 
protein (CRP) are major APPs, whereas haptoglobin (Hp) is a moderate APP (Piñeiro et al., 
2013; Pomorska-Mól et al., 2013; Quereda et al., 2012). However, in cattle, Hp is considered a 
major APP together with SAA and α1-acid glycoprotein (AGP) is a moderate APP (Ceciliani et 
al., 2012; Gånheim et al., 2007). A similar response to cattle occurs on goat, sheep and rabbit. In 
these three species, Hp and SAA are considered as major APPs (Eckersall et al., 2007; Gonzalez 
et al., 2008). In sheep, AGP and CRP show a moderate response after inflammation (Chemonges 
et al., 2014). Fibrinogen (FB) was also being described as a moderate APP in goat and rabbit 
(Cray et al., 2009). 
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2.2. APPs as stress biomarkers 
APPs had also been described as useful biomarkers in the assessment of animal welfare (Murata 
et al., 2004; Schrödl et al., 2016).  
Many researchers have investigated the potential use of APPs as indicators of stress. Although 
the mechanism of APP induction in response to stress is yet to be elucidated, activation of the 
HPA axis and the central and peripheral components of the ANS are responsible for crucial 
functions of the stress system (Kyrou et al., 2006). Inadequate, excessive or prolonged reactions 
to a stress condition may lead to a disease state and activate pathways involved in metabolism 
and immunity (Kyrou and Tsigos, 2009; McEwen, 1998). Glucocorticoids also lead to the 
production and release of APPs from liver into bloodstream (Murata, 2007; Tsigos and 
Chrousos, 2002). 
An increase in several APPs levels has been assessed in various species during road transport, 
indicating their potential use as an objective parameter to evaluate stress. A list of works that 
relate APPs as stress biomarkers is presented below: 
In cattle 
• Conner et al. (1988) have described the first increment of APPs in response to stress 
stimuli. Later, Alsemgeest et al. (1995) have reported that cattle stressed by housing on a 
slippery floor had effects on the concentrations of SAA. Saco et al. (2008) have also 
found SAA as an indicator of stress under different systems of housing and feeding. 
• Murata and Miyamoto (1993) found serum Hp concentrations increased after 1400 km 
over 2 days–transport, whereas Lomborg et al. (2008) have showed that the serum 
concentrations of Hp and SAA were already significantly increased after 4 to 6– hours of 
transport. 
• The effects of 5–hours of transport together with lairage for 48 h were showed to increase 
Hp and SAA concentrations immediately 24 hours after transport (Giannetto et al., 2011). 
In pig 
• Piñeiro et al. (2007) have evaluated the pig APP response after 24 and 48 hours–
transport. Pig-MAP, Hp, SAA and CRP were significantly increased. Salamano et al. 
(2008) that investigated the effects of a housing period following long road transport 
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observed the same. They found Hp, CRP and pig-MAP more increased after arrival than 
28 days after housing.  
• Soler et al. (2013) have proposed the use of SAA and cortisol, collected from saliva, as 
stress marker in pigs after a 45 min–short transport. SAA have shown a more prolonged 
response than cortisol, which has decreased immediately after arrival. 
• Hp were also identified as a marker for housing stress in pigs (Marco-Ramell et al., 
2016). 
Monitoring APP could be considered as useful marker of welfare during transport and routine 
management in animals. 
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2.3. APPs in poultry 
Major APPs described in poultry include α1-acid glycoprotein (AGP), C-reactive protein (CRP), 
Serum amyloid A (SAA), Haptoglobin-like protein (PIT54) and Ovotransferrin (OVT) (O'Reilly 
and Eckersall, 2014). 
 
2.3.1. α1-acid glycoprotein (AGP) 
In chickens, AGP has clinical significance (O'Reilly and Eckersall, 2014). AGP is one of the 
most important binding proteins in plasma, carrying out important anti-inflammatory and 
immunomodulatory roles to control inflammation (Luo et al., 2015). Furthermore, AGP can act 
as a non-specific antimicrobial agent, binding to LPS and inhibiting its activity and numerous 
drugs, sustaining their transport levels in the cells (Koppenol et al., 2015; Murata et al., 2004). 
Elevated serum AGP levels have been observed in chickens infected with various bacterial or 
viral pathogens (Inoue et al., 1997; Nakamura et al., 1996; Packialakshmi et al., 2016; Takahashi 
et al., 1994; Takahashi et al., 1998). 
 
2.3.2. Serum amyloid A (SAA) 
SAA is a major APP in vertebrates and can easily increase their concentration up to 1000–fold as 
response to a stimuli. SAA belongs to a family of apolipoproteins which is incorporated into 
high-density lipoprotein (HDL) and then it is released into the circulation (Benditt and Eriksen, 
1977). The major SAA function is to modulate HDL transport and metabolism during APR. In 
mammals, multiple SAA genes have been described (Uhlar and Whitehead, 1999; Upragarin et 
al., 2005) but in chicken just one SAA gene has been identified (Ovelgönne et al., 2001). 
Persistently elevated serum SAA levels in chicken may result in the formation of AA amyloid 
protein, a SAA precursor. The accumulation of this precursor is able to cause joint amyloidosis, 
showing signs similar with chronic arthritis (Landman, 1999; Woldemeskel, 2012). Chamanza et 
al. (1999) found SAA overexpressed in broilers after turpentine injection and Staphylococcus 
aureus infection. Asasi et al. (2013) detected significant increases in SAA in chickens infected 
with Infectious Bronchitis Virus (IBV). SAA was also identified as a useful APP to monitoring 
the progression of disease in falcons, reflecting the severity of inflammation (Caliendo et al., 
2013). 
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2.3.3. Haptoglobin-like protein (PIT54) 
Hp is the major hemoglobin-binding protein found in mammals. Under certain pathological 
conditions, hemoglobin may leak into the bloodstream in high concentrations that can be toxic 
for the surrounding tissues. This hemoglobin is then sequester by Hp, inhibiting its oxidative 
activity (Nielsen and Moestrup, 2009). In birds’ genome there is no gene coding a similar 
protein. Instead, the protein referred as PIT54 was identified, which seems to have the same role 
as Hp (Wicher and Fries, 2006). PIT54 belongs to the Scavenger receptor cysteine-rich (SRCR) 
superfamily and is composed by four repetitive SRCR domains. Until now, PIT54 is found only 
in avian species, having been identified in geese, ostriches, emus, chicken and Galapagos finches 
(Wicher and Fries, 2006; Wicher and Fries, 2010; Zylberberg et al., 2013). PIT54 (mammalian-
like Haptoglobin) has been associated with Staphylococcus gallinarium and S. aureus infections 
(Garcia et al., 2009; Millet et al., 2007), E. coli and Eimeria tenella infections (Georgieva et al., 
2010) and IBV infections (Asasi et al., 2013). 
 
2.3.4. C-reactive protein (CRP) 
CRP was the first APP been described and is one of the major APP in humans and dogs 
(Eckersall and Bell, 2010). CRP has the ability to binds directly to degenerating cells, residues 
and polysaccharides on bacteria, fungi, and parasites, acting as an opsonin. It can activate the 
complement system when bound to one of its ligands and can bind to phagocytic cells, 
interacting together with humoral and cellular systems of inflammation (Cray et al., 2009; Gruys 
et al., 2005; Marnell et al., 2005). CRP has also been identified in birds with E. coli, Pasturella 
multocida, S. aureus infection (Patterson and Mora, 1964), IBV (Seifi et al., 2014), birds infected 
with Salmonella typhimurium (Rauber et al., 2014) and in birds exposed to heat stress (Sohail et 
al., 2010). 
 
2.3.5. Ovotransferrin (OVT) 
The transferrins are a group of iron-binding glycoproteins present in vertebrates and 
invertebrates. In poultry, transferrin protein is an APP, which occurs as two forms with the same 
gene sequence expressed in liver and oviduct, called ovotransferrin (OVT). Both forms have the 
same amino acid sequence and protein structure, differing only in the extent of glycosylation and 
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composition of attached carbohydrate side groups (Thibodeau et al., 1978; Williams, 1968; Xie 
et al., 2002). In chicken, OVT is a positive APP, increasing its circulating concentration in 
response to a stimuli and remaining elevated as long as inflammation persists (Cray et al., 2009). 
OVT has the ability to sequester iron with high affinity, an essential nutrient for bacterial, 
limiting bacterial growth. Chickens infected with Staphylococcus spp., E. coli or parasites as E. 
maxima and E. tenella showed a significant increase in the levels of serum OVT (Chamanza et 
al., 1999; Rath et al., 2009). OVT concentrations were also higher when chickens were 
challenged with lipopolysaccharides (LPS) (Horrocks et al., 2011; Koppenol et al., 2015). 
 
 
There is no information available regarding APPs as road transport biomarkers in poultry; 
however they have been related with stress in birds. 
• Salamano et al. (2010) have found higher AGP concentration in laying hens reared in 
different housing system and subject to stressful events. 
• Stress by high temperature and overcrowding have increased serum AGP and OVT 
concentration in broilers laired at different stocking densities (Najafi et al., 2015).  
• Feed deprivation in poultry farming imposes stress to the birds and adversely affects their 
welfare. Serum levels of OVT and AGP were increased following 30 hours after feed 
deprivation (Najafi et al., 2016). 
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2.4. APPs extrahepatic expression 
Liver mostly produces APPs, but extrahepatic expression has been widely demonstrated. Meek 
and Benditt (1986) reported for the first time the extrahepatic expression of SAA in different 
mouse tissues: adrenal gland, small intestine, large intestine, lung, kidney, brain, heart, spleen, 
testis, skeletal muscle, stomach and pituitary. Kalmovarin et al. (1991) have also described APPs 
mRNA expression in a variety of mouse tissues. Since then, data on expression of APPs in 
extrahepatic tissues have arise constantly. 
• SAA family is known to be expressed in various normal extrahepatic tissues in humans 
(Urieli-Shoval et al., 1998), cattle (Berg et al., 2011; Lecchi et al., 2012), horses (Berg et 
al., 2011), rabbit, mink and mouse (Marhaug et al., 1997; Ramadori et al., 1985), even 
without any association with specific diseases; 
• Hp is a major APP in cattle and several investigations have described its extrahepatic 
expression (Cooray et al., 2007; Dilda et al., 2012; Lecchi et al., 2012); 
• AGP is also known to be expressed in many other tissues beside liver (Lecchi et al., 
2009; Liu et al., 2014; Rahman et al., 2015); 
• CRP is also synthesized by a variety of tissues (Agassandian et al., 2014; Calabro et al., 
2005; Jabs et al., 2003). 
The list where APPs were found so far includes tongue, trachea, esophagus, stomach, 
abomasum, forestomach, small and large intestine, tonsil, pancreas, spleen, lung, prostate, skin, 
kidney, pituitary, placenta, bladder, testis, ovary, uterus, mammary gland, bone marrow, lymph 
nodes, thymus, thyroid, monocytes, leukocytes, heart, brain, cerebellum, eye, adipose tissue, 
skeletal muscle, synovial membrane and adrenal gland. No information about the extrahepatic 
expression in poultry is presently available.  
In general, the extrahepatic expression rate is lower in healthy status in comparison to that of the 
liver, but it might increase considerably under local homeostasis disturbance (Figure 8). 
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Figure 8. APPs secretion by liver and extrahepatic tissues during healthy and injury condition. 
Extrahepatic APPs play several tissue-specific roles in a healthy state, provide local protection, and repair 
in the event of a local injury. 
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Chapter 3. MicroRNAs as welfare biomarkers 
 
3.1. MicroRNAs (miRNAs) 
MicroRNAs (miRNAs) comprise a large family of short nucleotides (19–24 nucleotides in 
length) that have emerged as key post-transcriptional regulators, and control many 
developmental and cellular processes in eukaryotic organisms. MiRNAs are non-coding RNAs 
that regulate messenger RNA (mRNA) or protein levels either by promoting mRNA degradation 
or by attenuating protein translation. 
In 1993, the first miRNAs were identified in Caenorhabditis elegans, a nematode (Lee et al., 
1993). Since then, miRNAs have been reported in a wide variety of organisms ranging from 
single-cell algae to humans, suggesting that miRNA-mediated biological function is an ancient 
and critical cellular regulatory element (Bartel and Chen, 2004; Zhao et al., 2007). The number 
of miRNAs in the genome appears to be correlated with the complexity of the developmental 
program, with mammals having the largest number of miRNAs. It has been estimated that more 
than 60% of mammalian mRNA is targeted by at least one miRNA (Friedman et al., 2009). 
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3.2. miRNAs biogenesis and regulation 
MiRNAs are processed from precursor molecules (pri-miRNAs), which are either transcribed by 
RNA polymerase II (RNAPII)-specific transcripts of independent genes or from introns of 
protein-coding genes (Krol et al., 2010). The pri-miRNAs fold into hairpins, acting as substrates 
for two members of the RNase III family of enzymes – Drosha and Dicer, operating in 
complexes with dsRNA-binding proteins (dsRBPs), for example DGCR8, transactivation-
responsive (TAR) RNA-binding protein (TRBP) and protein activator of PKR (PACT). MiRNAs 
biogenesis is illustrated in Figure 9. 
In the first step, the Drosha processes pri-miRNA into an ~70-nucleotide precursor hairpin (pre-
miRNA), characterized by a stem-loop structure, inside the nucleus. Some pre-miRNAs are also 
produced from short introns, called mirtrons, because of splicing and disbranching, avoiding the 
Drosha step. Then, pre-miRNAs are exported to the cytoplasm, via Exportin-5. Dicer, assisted by 
TRBP, processes pre-miRNA to a ~20-nucleotide miRNA/miRNA* duplex. One strand of this 
duplex – miRNA/miRNA*, representing a mature miRNA, is then incorporated into the miRNA-
induced silencing complex (miRISC) and the other strand (miRNA*) is degraded. As part of 
miRISC, miRNAs targets mRNAs and induce their translational repression or deadenylation and 
degradation. Deadenylation of mRNAs is mediated by glycine-tryptophan protein of 182 kDa 
(GW182), which interacts with Argonaute (AGO) proteins and act downstream of them. AGO 
are core components of the miRISC and different species express multiple AGO homologues 
(eg. AGO1–AGO4 in mammals). While the amino-terminal part of GW182 interacts with AGO, 
the carboxy-terminal part interacts with the poly(A) binding protein (PABP) and recruits the 
deadenylases CAF1 and CCR4.  
Argonaute RISC catalytic component 2 (AGO2) has dual functions in the processing of miRNA 
precursors and in target silencing. First, AGO2 functions as a Dicer co-factor in pre-miRNA 
processing, as part of the RISC-loading complex. AGO2, which has a robust RNaseH-like 
endonuclease activity, supports Dicer processing by cleaving the 3′ arm of some pre-miRNAs, 
thus forming an additional processing intermediate called AGO2-cleaved precursor miRNA (ac-
pre-miRNA) (Diederichs and Haber, 2007). Second, AGO2 is loaded with a guide miRNA 
strand, making an active miRISC (Chendrimada et al., 2004). 
 
 Figure 9. MiRNA biogenesis. Fo
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A miRNA regulates the expression of its target mRNA in three manners, depending on the 
degree of complementarity between them (Figure 10): 
• Translational repression; 
• Cleavage of the target mRNA; 
• mRNA deadenylation. 
The small size of miRNAs provides a limited amount of sequence information for specificity. A 
partial pairing between a miRNA and a target is often sufficient. In animals, the vast majority of 
miRNAs only forms partial complementation with their targets, and the most mRNAs targets 
studied to date are regulated through 3’untranslated region (3’UTR) interactions. Nucleotides 2 
to 8 at the 5’ end of the miRNA, also called “seed” sequence, must be perfectly complementary 
to the target (Bartel, 2004; Pasquinelli, 2012). 
An imperfect complementarity leads to translational repression whereas a perfect or nearly 
perfect complementarity leads to cleavage of the target mRNA by endonucleotic cleavage 
activity of AGO (Wang et al., 2013). Some animal miRNAs can cause the cleavage of their 
target mRNAs despite imperfect complementarity between them (Yekta et al., 2004). Binding of 
the miRISC, which includes GW182 protein to 3’UTR target sequences can result in the 
recruitment of deadenylation factors that remove the poly(A) tail and make the mRNA 
susceptible to degradation (Wu et al., 2006). 
 
 
Figure 10. MiRNAs regulate gene expression through multiple pathways. Translational repression can be 
induced by blocking translation initiation. Perfect pairing between miRNA and its target induces 
endonucleolytic cleavage by AGO, leading to rapid degradation of the mRNA. Partial pairing of the 
miRNA complex and its target to 3’UTR site can result in deadenylation of the mRNA. Adapted from 
Fazi and Nervi (2008). 
Target mRNA
Cleavage
Repression
Deadenylation
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Transcription of miRNA genes is regulated in a similar manner to that of protein-coding genes. 
A common regulatory mechanism for miRNA gene expression is by regulatory feedback loops. 
MiRNAs can participate in feedback circuits and repress mRNA that encode factors involved in 
the biogenesis or function of the same miRNA (Ha and Kim, 2014; Krol et al., 2010). 
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3.3. miRNAs involved in cellular stress pathways 
MiRNAs have been identified in animal species as markers for various biological processes. 
They play key roles in immune system, act as specific targets for inflammation and contribute 
for the diagnosis of a variety of diseases and stress disorders (Andersen et al., 2014; Rebane and 
Akdis, 2013; Wang et al., 2013). 
There is a link between the Dicer complex and the cellular stress response (Figure 11). When the 
cell senses a stress signal, Dicer modifications can activate or inhibit miRNAs. Stressors, such as 
reactive oxygen species (ROS), UV radiation or type I interferons (IFNs), cause a reduction in 
the expression of Dicer (Wiesen and Tomasi, 2009). Loss of Dicer function reduces stress 
tolerance, whereas Dicer overexpression confers stress resistance. In addition, Dicer co-factors – 
AGO, PACT and TRBP, which participates in the connection between Dicer and miRISC 
complex, can be influenced by stress. Stress signalling can interfere with AGO2 function by 
post-translational modifications.  
Under stress, three modifications can alter AGO2, which loses its capacity to bind Dicer 
complex and, consequently, inhibits pre-miRNA processing. P38/MAPK phosphorylates AGO2 
at Serine 387, epidermal growth factor receptor (EGFR) modifies tyrosine 393, and/or proline 
700 can be hydroxylated (Emde and Hornstein, 2014). These post-translational modifications 
contribute to AGO2 translocation into stress granules (SGs). SGs are known to be sites where 
miRNAs accumulate when the cell is under stress, and contain enzymes responsible for miRNA 
decapping, deadenylation and degradation (Anderson and Kedersha, 2006). 
PACT and TRBP participate in the cellular stress response via interaction with PKR. PKR is an 
interferon-induced dsRNA-regulated protein kinase, which binds to dsRNA and is involved in 
the host inflammatory response. PKR phosphorylates eukaryotic translation initiation factor 2α 
(eIF2α), activating SGs and, thereby, causing global reduction of protein synthesis (Taylor et al., 
2005). AGO2 and PACT are recruited into stress granules, together with other proteins involved 
in miRNA regulation pathways (Emde and Hornstein, 2014). Stress response is also extended to 
the regulation of miRISC activity, leading to miRNA degradation. 
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Chapter 4. Adipose tissue 
 
Adipose tissue (AT) is a loose connective tissue, distributed as fat depots throughout the whole 
body and being a necessary survival characteristic of the organism during periods of famine. In 
humans, AT has an important role in the obesity and overweight. However, in farm animals, 
obesity is not an issue, due to the controlled environment in which they live. Actually, it has 
been demonstrated that AT influences animal health and meat quality, and has an economic 
value by affecting parameters such as tenderness, juiciness and taste (Wood et al., 2008). 
Fat depots are mainly classified as subcutaneous or visceral adipose tissue. Subcutaneous AT 
includes depots located beneath the skin, whereas visceral AT is located in the intra-abdominal 
cavities, surrounding specific organs, such as kidney and heart, or distributed among peritoneum 
layers, such as mesenteric and omental fat. Subcutaneous and visceral AT have unique 
adipokines expression profiles, and different metabolic characteristics (Ibrahim et al., 2010; 
Peinado et al., 2010). Figure 12 presents the major location of visceral and subcutaneous AT 
depots in chicken. 
 
 
Figure 12. The distribution of subcutaneous and visceral adipose tissue in chicken. Adapted from 
Sauerwein et al. (2014). 
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For a long time, AT has been considered as a passive organ of energy storage. In 1994, AT was 
identified as the source of the hormone leptin, transforming the tissue in an active participant in 
hormonal regulation of homeostasis (Zhang et al., 1994). Since then, AT was proved to be 
involved at countless pathways such as homeostasis and metabolic regulation, reproduction, as 
well as innate and adaptive immune response, through production and secretion of messenger 
molecules which are called as “adipokines” (Cunningham et al., 1999; Kershaw and Flier, 2004; 
Lord, 2002; Rajala and Scherer, 2003).  
Adipokines include a wide range of hormones and chemokines, produced exclusively by AT 
(e.g. leptin, adiponectin and visfatin), and molecules involved in the immune system (e.g. 
interleukins, cytokines and APPs) (Figure 13) (Deng and Scherer, 2010; Sauerwein et al., 2014).  
 
 
Figure 13. Example of adipokines synthesized and secreted from adipose tissue and their main functions. 
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The role of the adipocytes as a hormone and cytokine secreting cells has already been clarified 
(Wisse, 2004). Adiposity has been correlated with the higher number of macrophages in obese 
animals, which tends to aggregate and form cells characteristic of chronic inflammation 
(Weisberg et al., 2003). Pre-adipocytes are also potent phagocytes similar to macrophages in 
both morphology and pattern of gene expression (Cousin et al., 1999). The AT production of 
leptin increases during acute infection and fat contributes to elevated circulating TNF-α, TGF-
β1, IL-1β, IL-6, IL-8, IL-10, as well as other factors that participate directly in immune response 
(e.g. APP) (Trayhurn and Wood, 2004; Vettor et al., 2005). Moreover, the fact that a list of 
adipokines are involved in inflammation has lead to the view that the obesity is state of chronic 
low-grade inflammation, relating acute phase response with metabolic syndrome. Visceral 
depots are known by having a higher lipolytic activity and expression of pro-inflammatory 
cytokines than subcutaneous depots (Wronska and Kmiec, 2012). Although the AT contribution 
to the secretory inflammatory cytokines has been addressed in animals, the role of AT in the 
immunologic pathways is unknown in poultry.  
Adipose tissue seems to be very reactive to a stress condition and there is an intricate 
relationship between the systems that are activated in response to stress and the metabolism. 
Glucocorticoids are the main stress effectors produced after the activation of HPA axis and they 
leads to a redistribution of energy sources (e.g. increased glucose production, adipocyte 
differentiation and increasing the visceral adiposity) (Chrousos, 2000; Pasquali et al., 2006). 
Glucocorticoids mediate the conection between adipocytes and the HPA axis, linking obesity and 
metabolic diseases with stress-related pathologies (Kloet et al., 2015; Peckett et al., 2011). 
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Chapter 5. Experimental designs and results 
 
Some aspects are of particular relevance when we planned our experimental design related with 
poultry species: 
- Information about turkey (Meleagris gallopavo) are scarce in literature. There is no available 
information regarding how to evaluate welfare in this species, especially for what concerns APPs 
and miRNAs as welfare biomarkers. On the contrary, this species is very important from an 
economic perspective. 
- Chicken (Gallus gallus) is the closest species and we resorted to this to complete the missing 
information in turkey. 
In this study, APP and miRNAs were characterized for the first time as molecular welfare 
biomarkers and as markers for stress-related transport in turkey species. Intestinal mucosa 
proteome was also characterized in healthy animals and in the presence of a gastrointestinal 
disease. The distribution of APP extrahepatic expression was studied in poultry, in this case in 
chicken species. 
The results of this investigation are presented in this thesis in two published papers, in two 
papers ready for publication and in a project still going on: 
 
Paper 1 (pp 64-84): Widespread extrahepatic expression of acute phase proteins in healthy 
chicken (Gallus gallus) tissues – Andreia Tomás Marques, Laura Nordio, Cristina Lecchi, Guido 
Grilli, Chiara Giudice, Fabrizio Ceciliani. Submitted to Veterinary Immunology and 
Immunopathology. 
 
Paper 2 (pp 85-106): The effect of transport stress on turkey (Meleagris gallopavo) liver acute 
phase proteins gene expression – Andreia Tomás Marques, Cristina Lecchi, Guido Grilli, Chiara 
Giudice, Sara Rota Nodari, Leonardo James Vinco, Fabrizio Ceciliani. Research in Veterinary 
Science. 2016 Feb;104:92-5. doi: 10.1016/j.rvsc.2015.11.014. 
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Paper 3 (pp 107-119): Circulating extracellular miR-22, miR-155, and miR-365 as candidate 
biomarkers to assess transport-related stress in turkeys – Cristina Lecchi, Andreia Tomás 
Marques, Miriam Redegalli, Sarah Meani, Leonardo James Vinco, Valerio Bronzo, Fabrizio 
Ceciliani. Animal. 2016 Jul;10(7):1213-7. doi: 10.1017/S1751731115003043. 
 
Paper 4 (pp 120-165): Proteome analysis of intestinal mucosa in turkey (Meleagris gallopavo) 
infected with haemorrhagic enteritis virus – Andreia Tomás Marques, Sandra Anjo, Mangesh 
Bhide, Ana Varela Coelho, Cristina Lecchi, Guido Grilli, Bruno Manadas, Fabrizio Ceciliani. To 
be submitted to Journal of Proteomics. 
 
The experimental design planned for this thesis is presented in Figure 14. 
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The main aims for each study are summarized below: 
 
Chapter 5.1. Widespread extrahepatic expression of acute phase proteins in healthy 
chicken (Gallus gallus) tissues 
The aim of the present study was to investigate the distribution pattern of the five major APPs in 
twenty tissues collected from six healthy chicken. 
The study was carried out by measuring APP mRNA with quantitative Real Time PCR and by 
immunohistochemistry to detect AGP and OVT localization, using available antibodies, in order 
to understand their potential source, role in local immunity, and their impact in chicken welfare. 
 
Chapter 5.2. The effect of transport stress on turkey (Meleagris gallopavo) liver and 
adipose tissue acute phase proteins gene expression  
The aim of this study was to identify the major APP in turkey species and evaluate their potential 
use as indicators of transport stress.  
- In a first instance, we focused our attention on the liver gene expression and, where 
antibodies were available, at protein level.  
- In the second part of the study, the gene expression modification of APP mRNA and protein 
localization was extended to visceral adipose tissue.  
- In the last part of the study, we tried to produce antibodies against CRP and PIT54, since 
there is already an antibody against AGP and a comercial assay for SAA available in 
poultry. 
The study was carried out by measuring APP mRNA abundance by quantitative Real Time PCR 
and immunohistochemistry to detect AGP localization, after validating an anti-AGP antibody by 
Western blotting. Antibodies against CRP and PIT54 proteins were also raised and validated in 
turkey species. 
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Chapter 5.3. Circulating extracellular miR-22, miR-155, and miR-365 as candidate 
biomarkers to assess transport-related stress in turkey (Meleagris gallopavo) 
The aim of the present study was to determine whether transport-related stress modulates the 
expression of circulating miRNA and investigate the potential use of differentially expressed 
miRNA as biomarkers to measure transport-related stress. Five miRNAs, previously 
demonstrated to be related to stressful events in chicken and immune defenses, were selected for 
our study and road-transportation was identified as stressful model. 
The study was carried out by measuring those miRNAs by quantitative Real Time PCR using 
TaqMan probes. 
 
Chapter 5.4. Proteome analysis of intestinal mucosa in turkey (Meleagris gallopavo) 
infected with haemorrhagic enteritis virus  
The aim of this work was to undertake in-depth and comparative studies of the protein 
expression pattern of turkey intestinal mucosa. Currently, proteomic studies in poultry are 
limited to chicken. To the best of our knowledge, no proteomic data about intestine is available 
in turkey.  
A SWATH-MS strategy was used to characterize and compare the proteome composition from 
healthy and HEV-affected turkeys.  
 
Chapter 5.5. Acute phase proteins mRNA changes in the liver, adipose tissue and jejunum 
of turkeys (Meleagris gallopavo) infected with haemorrhagic enteritis virus 
The aim of this study was to evaluate the APP potential use as indicators of a heamorrhagic 
enteritis disease in turkeys. The APP gene expression was quantified in liver, adipose tissue and 
jejunum, the tissue were the lesions were found, in both healthy and sick turkeys. 
The study was carried out by measuring APP mRNA abundance by quantitative Real Time PCR. 
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5.1. Widespread extrahepatic expression of acute phase proteins in 
healthy chicken (Gallus gallus) tissues 
 
Manuscript of this work is submitted to Veterinary Immunology and Immunopathology: 
Widespread extrahepatic expression of acute phase proteins in healthy chicken (Gallus 
gallus) tissues. 
Andreia Tomás Marquesa*, Laura Nordioa, Cristina Lecchia, Guido Grillia, Chiara Giudicea, 
Fabrizio Ceciliania 
a
 Department of Veterinary Science and Public Health, Università di Milano, Via Celoria 10, 
20133 Milano, Italy. 
 
* Corresponding author: Andreia Tomás Marques  
Department of Veterinary Medicine – Università degli Studi di Milano, Via Celoria, 10 - 20133 
Milan (Italy). E-mail address: andreia.tomas@unimi.it 
 
Keywords: acute phase proteins, animal welfare, chicken, extrahepatic expression, Gallus 
gallus. 
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Abstract 
 
Acute phase proteins (APPs) are plasma proteins that can modify their expression in response to 
inflammation caused by tissue injury, infections, immunological disorders, or stress. Although 
APP are produced mainly in liver, extrahepatic production has also been described. The aim of 
this work was to study the extrahepatic expression of five APP, namely AGP, SAA, PIT54, CRP 
and OVT in twenty tissues collected from healthy chicken (Gallus gallus) by quantitative Real 
Time PCR and immunohistochemistry. As expected, APP gene expression was higher in liver 
compared with other tissues. The mRNA coding for CRP, OVT and SAA was detected in all 
analyzed tissues with a higher expression in gastrointestinal tract, respiratory and lymphatic 
samples. SAA expression was particularly high in cecal tonsil, lung, spleen and Meckel’s 
diverticulum, whereas OVT in lung, bursa of Fabricius and pancreas. AGP and PIT54 mRNA 
expression were detected in all tissues but at very low levels. Immunohistochemical expression 
of AGP and OVT was variably detected in different organs, being identified in endothelium of 
every tissue. Positive cells were present in the epithelium of the mucosal layer of gastrointestinal 
tract and kidney. Lung and central nervous system stained for both proteins. No positive staining 
was detected in lymphoid tissues and muscle. These results suggest that each tissue is able to 
express different amount of APP even in healthy conditions and mount a local acute phase 
reaction.  
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1. Material and methods 
 
1.1. Samples collection and preservation 
The samples were collected during routinely slaughtering procedures from six healthy female 
chicken, 55 days old (Table 1). The clinical status of the animals was assessed by ante- and post-
mortem inspection. Figure 1 presents the chicken anatomy. 
Portions of each tissue were removed immediately after slaughtering, preserved in RNAlater 
(Sigma–Aldrich) or frozen into liquid nitrogen and afterwards stored at −80ºC before RNA 
extraction. Adipose tissue was stored without previous immersion in RNAlater. Samples for 
immunohistochemistry analysis were fixed in 10% buffered formalin. 
 
Table 1. Samples list. 
Adipose tissue 
Subcutaneous adipose tissue  
Visceral adipose tissue  
Pericardial adipose tissue  
Muscular system Pectoral muscle  
Lymphatic system 
Thymus  
Spleen  
Cecal tonsil  
Bursa of Fabricius  
Central nervous system 
Brain  
Cerebellum  
Urogenital system Kidney  
Respiratory system Lung  
Gastrointestinal tract 
Crop  
Stomach 
Mucosa of proventriculus 
Mucosa of gizzard 
Pancreas  
Intestine 
Duodenum 
Caecum 
Meckel's diverticulum  
Liver  
67 
 
 
Figure 1. Chicken anatomy. A, general anatomy; B, gastrointestinal tract anatomy in detail. Images 
available in Pinterest (https://www.pinterest.com) and modified. 
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1.2. Qualitative and quantitative mRNA expression 
Total RNA was extracted using QIAzol lysis reagent according to the manufacturer’s protocol 
(Qiagen) and treated with DNase I (Thermo Fisher Scientific, Fermentas). Total RNA was 
quantified using a NanoDrop ND-1000 UV–vis spectrophotometer. Reverse transcription was 
carried out with 1 µg RNA using the iScript cDNA Synthesis Kit (BioRad). The cDNA was used 
as template for PCRs. 
Qualitative PCR was performed in 10 µL final volume containing 1x buffer, 1.5 mM MgCl2, 0.2 
mM each deoxynucleotide triphosphate (dNTP), 1 µM each primer and 0.025 U Taq polymerase 
(LeGene Biosciences). PCR conditions were 35 cycles of 94ºC for 30 sec, 60ºC for 30 sec and 
72ºC for 45 sec (Eppendorf Mastercycler). PCR products were visualized on 1.6% agarose gel 
stained with ethidium bromide. The same primers were used in qualitative and quantitative PCR 
(Table 2). 
 
Table 2. List of the genes under study and their respective primers sequences, accession 
numbers and fragment lengths. 
Gene GenBank Primer Forward (5’-3’) Primer Reverse (5’-3’) 
Length 
(bp) 
AGP NM_204541.2 GGTGTACATCATGGGTGCCT CGCATGTTTCATTCAGCCTCA 143 
SAA XM_003206257.1 TGCTTCGTGTTGCTCTCCAT CATGTCCCGGTATGCTCTCC 123 
PIT54 XM_003202017 GCCAGTGCAATTTGTTCAGA TCCCGTAAATCCCAGTTGTC 146 
CRP EU106581.1 ATCCCATGCTCAACTTCACC CCGACGTAGAAGCGGTACTC 145 
OVT NM_205304.1 AGCCATTGCGAATAATGAGG ATGGGCTTCAGCTTGTATGG 90 
GAPDH GQ184819.1 GATCCCTTCATCGACCTGAA ACAGTGCCCTTGAAGTGTCC 77 
RPL4 XM_003209573.1 TGTTTGCCCCAACCAAGACT TCCTCAATGCGGTGACCTTT 136 
YWHAZ XM_003205203.1 TTCCCTTGCAAAAACGGCTT TTCAGCTTCGTCTCCTTGGG 148 
AGP, alpha 1-acid glycoprotein; SAA, serum amyloid A; PIT54, scavenger receptor cysteine-rich domain-containing 
protein LOC284297 homolog (haptoglobin-like); CRP, C-reactive protein; OVT, ovotransferrin; GAPDH, 
glyceraldehyde 3-phosphate dehydrogenase; RPL4, ribosomal protein L4; YWHAZ, tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein, zeta. SAA, PIT54, CRP, GAPDH, RPL4 and YWHAZ 
were from Marques et al. (2016). AGP and OVT primers were designed using Primer 3 (http://bioinfo.ut.ee/primer3-
0.4.0). 
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Quantitative real time PCR (qPCR) was performed using 12 µL Eva Green Supermix (BioRad), 
250 nM AGP and PIT54, 300 nM SAA, CRP and OVT and 400 nM GAPDH, YWHAZ and 
RPL4 primers, using Eco Real-Time PCR System (Illumina). GAPDH, RPL4 and YWHAZ were 
selected as reference genes based on previous studies and literature (Yang et al., 2013; Yue et al., 
2010).  
In order to evaluate the PCR efficiency using a relative standard curve, series of dilution were 
prepared by performing fourfold serial dilution starting from the pooled sample composed by a 
liver cDNA mix from six animals. Each sample was tested in duplicate. Non-reverse transcribed 
controls were performed by omitting reverse transcription and no template controls were 
conducted by adding nuclease free water. The thermal profile used (95°C for 10 min, 40 cycles 
of 95°C for 10 sec and 60°C for 30 sec; for melting curve construction, 55°C for 15 sec and 80 
cycles starting to 55°C and increasing 0.5°C each 10 sec) was the same for each target gene. The 
MIQE guidelines were followed (Bustin et al., 2009). For all genes studied, the standard curves 
derived from serial dilution of pooled sample gave correlation coefficients (R2) greater than 
0.990 and efficiencies greater than 94%. Results were compared using the comparative ∆-∆Cq 
method. 
 
1.3. Western blotting analysis 
Western blotting analysis was carried out on chicken serum using an anti-bovine AGP antibody. 
Proteins were separated on a 12% sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS–PAGE) and blotted onto nitrocellulose membrane. Before gel separation, 1 µl ß-
mercaptoethanol (Sigma Aldrich) was added to each sample. Immunolabeling was performed 
using a rabbit polyclonal anti-bovine AGP (Ceciliani et al., 2007) as primary antibody (1:4000 
dilution for 1 h min at RT), while an anti-rabbit IgG labelled with peroxidase (Vector 
Laboratories) was used as secondary antibody (1:4000 dilution for 45 min at RT). 
Immunoreactive bands were visualized by enhanced chemiluminescence (ECL) using Immobilon 
Western Chemiluminescent HRP Substrate (Millipore).  
To further assess the specificity of the antibody for chicken protein, Western blotting experiment 
was repeated after overnight incubation of the anti-boAGP antibody with purified bovine AGP 
using a 1:10 molar ratio, in order to block every anti-AGP specific reactive sites and to detect 
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any possible non-specific reactions. The solution was then utilized as primary antibody in 
immunolabeling detection procedure (1:4000 dilution  for  1 h  at  RT). 
 
1.4. Immunohistochemistry studies 
The immunolocalization was carried out as previously described (Rahman et al., 2015). 
Formalin-fixed tissue specimens were routinely processed for histology and paraffin embedded. 
Sections of 5 µm thick were obtained from paraffin blocks and mounted on poly-lysine-coated 
slides.  
The sections were then deparaffinized in xylene and rehydrated through a descending series of 
ethanol concentrations. The endogenous peroxidase activity was blocked with 0.3% H2O2 in 
methanol for 30 min. Antigen retrieval was performed by heating the slides in citrate buffer 
solution (pH=6.5) in a water bath at 95°C for 30 min. The sections were cooled for 40 min at RT 
and then rinsed in Tris buffered saline (TBS). The slides were therefore incubated for 20 min at 
RT with normal goat serum (1:70) to block any nonspecific protein binding. Sections were 
incubated at 4°C overnight in a humidified chamber with primary antibodies: polyclonal rabbit 
anti-AGP, 1:200 (Ceciliani et al., 2007); polyclonal rabbit anti-OVT, 1:800 (MyBioSource). 
The sections were then rinsed in TBS for 3 times of 3 min each and then incubated with 
PolyView mouse/rabbit nanopolymer detection reagents (Enzo Life Sciences) for 20 min at RT. 
After three washes in TBS, the chromogen 3-amino-9-ethylcarbazole (AEC) (Vector 
Laboratories) was applied for 20 min and, after rinsing in tap water, slides were counterstained 
with Mayer’s haematoxylin (Diapath srl) for 2 min. Slides were therefore rinsed in tap water for 
5 min, dried in a stove at 45°C for 12 h and therefore mounted in aqueous mounting agent 
(Aquatex, Merck). Immunohistochemical staining was evaluated and semi-quantitatively scored 
as mild, moderate or intense. Histological sections of liver served as positive controls. 
Additionally, paraffin embedded samples of oviduct from normal hens were retrieved from the 
departmental archives and served as positive controls for OVT. Negative controls were prepared 
by replacing the respective primary antibody with normal rabbit IgG (Santa Cruz 
Biotechnology). 
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1.5. Statistical analysis 
For all statistical procedures, mean and standard error of the mean (SEM) values were 
calculated. Student t-test, with a two-tailed distribution and an homoscedastic variance was used 
for all statistical analyses. Significance accepted for p-values ≤ 0.05. 
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Table 3. Extrahepatic expression of APP ± standard error of the mean (SEM) compared to 
liver expression values (set to 1). Data shows the mean value of 6 animals. 
Tissues 
Genes 
AGP SAA PIT54 CRP OVT 
Subcutaneous adipose 
tissue 
5.30E-05 ± 0.0000 7.26E-02 ± 0.0495 9.49E-05 ± 0.0001 6.26E-03 ± 0.0030 6.67E-02 ± 0.0130 
Visceral adipose tissue 3.05E-05 ± 0.0000 1.33E-02 ± 0.0033 2.10E-05 ± 0.0000 3.17E-02 ± 0.0197 9.93E-02 ± 0.0503 
Pericardial adipose 
tissue 
5.27E-04 ± 0.0005 1.38E-01 ± 0.0310 3.65E-04 ± 0.0003 9.38E-03 ± 0.0030 1.89E-01 ± 0.0330 
Pectoral muscle 9.70E-06 ± 0.0000 2.38E-03 ± 0.0010 8.24E-06 ± 0.0000 2.65E-04 ± 0.0002 3.41E-03 ± 0.0009 
Thymus 2.05E-05 ± 0.0000 7.09E-02 ± 0.0201 3.27E-04 ± 0.0001 1.91E-03 ± 0.0009 8.55E-03 ± 0.0019 
Spleen 8.70E-04 ± 0.0003 2.57E-01 ± 0.0631 9.99E-04 ± 0.0003 1.08E-03 ± 0.0004 1.91E-02 ± 0.0028 
Brain 1.23E-04 ± 0.0000 9.32E-03 ± 0.0037 1.45E-04 ± 0.0000 5.90E-02 ± 0.0576 1.08E-01 ± 0.0273 
Cerebellum 7.58E-05 ± 0.0000 1.68E-02 ± 0.0070 1.02E-04 ± 0.0000 3.53E-04 ± 0.0001 1.07E-01 ± 0.0330 
Kidney 9.67E-04 ± 0.0004 6.56E-02 ± 0.0274 5.59E-04 ± 0.0002 3.69E-03 ± 0.0013 3.44E-02 ± 0.0097 
Lung 5.33E-04 ± 0.0003 6.94E-01 ± 0.3031 2.91E-04 ± 0.0002 8.14E-03 ± 0.0033 2.59E-01 ± 0.0676 
Crop 3.48E-05 ± 0.0000 3.79E-02 ± 0.0276 4.76E-05 ± 0.0000 2.99E-04 ± 0.0002 1.40E-02 ± 0.0073 
Mucosa of 
proventriculus 
3.40E-04 ± 0.0001 1.36E-02 ± 0.0036 2.26E-04 ± 0.0001 7.35E-03 ± 0.0056 2.78E-02 ± 0.0044 
Mucosa of gizzard 1.55E-04 ± 0.0001 1.16E-01 ± 0.0507 2.06E-04 ± 0.0002 5.22E-03 ± 0.0020 3.51E-02 ± 0.0103 
Pancreas 1.45E-04 ± 0.0001 3.30E-02 ± 0.0117 2.67E-04 ± 0.0001 2.21E-03 ± 0.0010 1.12E-01 ± 0.0253 
Duodenum 1.61E-05 ± 0.0000 1.83E-02 ± 0.0068 1.26E-04 ± 0.0001 6.41E-04 ± 0.0003 1.78E-02 ± 0.0135 
Meckel's diverticulum 6.61E-06 ± 0.0000 2.06E-01 ± 0.1290 1.34E-05 ± 0.0000 5.44E-03 ± 0.0047 3.13E-02 ± 0.0227 
Caecum 1.77E-05 ± 0.0000 2.41E-02 ± 0.0059 7.65E-06 ± 0.0000 5.71E-04 ± 0.0001 8.39E-03 ± 0.0012 
Cecal tonsil 5.08E-05 ± 0.0000 7.22E-01 ± 0.2917 1.93E-05 ± 0.0000 8.26E-04 ± 0.0002 4.11E-02 ± 0.0113 
Bursa of Fabricius 5.23E-05 ± 0.0000 3.00E-02 ± 0.0134 3.39E-05 ± 0.0000 2.68E-03 ± 0.0013 1.26E-01 ± 0.0280 
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mRNA coding for SAA, CRP and OVT was detected in all tissues analysed, although its 
concentration appeared to vary considerably between different tissues (Figure 3). Its amounts 
ranged from 0.002 to 0.72, 0.001 to 0.06 and 0.003 to 0.26, respectively, as compared to liver, 
with cecal tonsil and lung having the highest concentration. SAA mRNA expression was higher 
in cecal tonsil, lung, spleen, Meckel’s diverticulum, pericardial adipose tissue and mucosa of 
gizzard (0.72, 0.69, 0.26, 0.21, 0.13 and 0.12, respectively). CRP mRNA expression was high 
just in brain and visceral adipose tissue (0.06 and 0.03, respectively). OVT was more expressed 
in lung, followed by pericardial adipose tissue and bursa of Fabricius (0.26, 0.19 and 0.13, 
respectively), whereas brain, cerebellum, pancreas, visceral adipose tissue and subcutaneous 
adipose tissue showed around 0.10 mRNA expression. 
Expression of AGP and PIT54 was lower as compared to liver (from 0.0001 to 0.001). 
Nonetheless, both APP were detected in all the tissues (Figure 4). 
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Figure 3. Relative extrahepatic expression of SAA, OVT and CRP in chicken healthy tissues studied by 
qPCR. Liver was used as reference tissue and data are means ± SEM of six animals. 
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Figure 4. Relative extrahepatic expression of AGP and PIT54 in chicken healthy tissues studied by 
qPCR. Liver was used as reference tissue and data are means ± SEM of six animals. 
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2.2. Validation of anti-bovine AGP antibody by Western blotting 
To the best of our knowledge, no antibody specific for chicken CRP, PIT54 and SAA has also 
been reported in literature so far, but there is a commercial antibody available for OVT. Then, 
attention was focused on validating an antibody against AGP, already validated for turkey 
species (Marques et al., 2016), but not in chicken. The presence of AGP was confirmed by 
Western blotting using an anti-bovine AGP antibody (Ceciliani et al., 2007) that was shown to 
cross-react with a most prominent band with a molecular weight (MW) of 55–65 kDa in serum 
(Figure 5). 
 
 
Figure 5. Detection of chicken AGP by Western blotting in serum. Left panel: anti-boAGP primary 
antibody. Right panel: anti-boAGP primary antibody after blocking specific sites with purified bovine 
AGP. 
 
2.3. Localization of APPs in chicken tissues by immunohistochemistry 
No antibodies specific for chicken CRP, PIT54 and SAA are available. Immunohistochemistry 
studies were then performed using only AGP and OVT antibodies. A polyclonal anti-chicken 
OVT was purchased (MyBioSource) and a polyclonal anti-bovine AGP antibody (Ceciliani et 
al., 2007) was validated in chicken. 
The presence of AGP and OVT proteins was clearly identified in endothelium of every tissue, 
confirming they are circulating proteins that can easily reach any tissue by bloodstream. At 
immunohistochemical examination, liver and oviduct were used as positive controls and stained 
for AGP and both AGP and OVT, respectively. Immunohistochemical expression of AGP and 
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OVT was variably detected in tested tissues, with similar pattern of expression for both markers 
(Figure 6). Detailed results are given in Table 4. 
Briefly, multifocal positivity was detected in adipose and connective tissue for both AGP and 
OVT. Scattered positive cells, for both markers, were variably present in the epithelium of the 
mucosal layer of organs of the gastrointestinal tract (crop, mucosa of proventriculus, duodenum, 
caecum and meckel’s diverticulum). In the liver, hepatocytes were mildly and diffusely positive, 
whereas ductal epithelium exhibited intense multifocal granular intracytoplasmic positivity, as 
also seen in kidney tubular epithelium. Pancreatic islets were intensively positive but acini 
always negative. Lung was diffusely positive in its different anatomic regions. Central nervous 
tissue was multifocally positive according to different areas. No positive staining was detected in 
lymphoid tissues (thymus, intestinal Peyer’s patches, bursa of Fabricius, spleen) and muscle. 
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Figure 6. Immunolocalization of AGP and OVT in chicken. Immunohistochemical staining (standard 
ABC method, AEC red chromogen). A, subcutaneous adipose tissue, anti-AGP, 10X: multifocal positive 
adipose tissue surrounding a central arterial vessel with negative tunica media and positive endothelium 
(inset). B, mucosa of proventriculus, anti-OVT, 20X: diffuse positivity in the basal portion of mucosal 
columnar epithelium. C, pancreas, anti-OVT, 20X: positive islet and negative acini. D, liver, anti-OVT, 
20X: multifocal intense positivity in ductal epithelium and mild diffuse positivity in hepatocytes section 
of liver. Bar, 25 and 50 micrometers.  
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Table 4. Results of the immunohistochemical examination.  
Tissue 
 
AGP OVT 
Subcutaneous 
adipose tissue 
Adipocytes 
+ (intense, with scattered less 
positive) 
+ (multifocal to diffuse intense) 
Connective tissue + (multifocal) + (multifocal) 
Visceral adipose 
tissue 
Adipocytes + (intense multifocal to diffuse) + (multifocal) 
Connective tissue + (multifocal) + (multifocal) 
Pericardial 
adipose tissue 
Adipocytes + (diffuse) + (multifocal) 
Pectoral muscle Muscular fibers Negative Negative 
Thymus Lymphocytes Negative Negative 
Spleen Lymphocytes Negative Negative 
Brain 
Neurons + (mild diffuse) + (mild diffuse) 
Axons Negative Negative 
Choroid plexus + (diffuse) + (diffuse) 
Cerebellum 
White matter Negative Negative 
Granule cell layer, 
Purkinje cell layer 
Negative Negative 
Molecular layer + (mild) + (mild) 
Kidney 
Tubular epithelium + (multifocal cytoplasmic) 
+ (multifocal granular 
cytoplasmic) 
Glomeruli Negative Negative 
Lung 
Parabronchi, atria, air 
capillaries, bronchi 
+ + 
Crop 
Epithelium 
stratum corneum: +, stratum 
lucidum and stratum granulosum: 
-, stratum spinosum and stratum 
basale: + 
stratum corneum: +, stratum 
lucidum and stratum granulosum: 
-, stratum spinosum and stratum 
basale: + 
Muscle Negative Negative 
Mucosa of 
proventriculus 
Mucosal columnar 
epithelium 
+ (in the basilar zone of the 
cytoplasm) 
+ (in the basilar zone of the 
cytoplasm) 
Ductal epithelium + (faint diffuse) + (moderate multifocal) 
Oxynticopeptic cells + (faint patchy) + (faint patchy) 
Mucosa of gizzard Epithelium, koilin, muscle Negative Negative 
Pancreas 
Islets + (intense) + (intense) 
Acini Negative Negative 
Intestine 
Duodenum, ceacum 
epithelium, Meckel’s 
diverticulum epithelium 
+ (mild scattered single cells) + (mild scattered single cells) 
Lymphoid follicles (GALT, 
cecal tonsil) 
Negative Negative 
Bursa of Fabricius 
Lymphocytes Negative Negative 
Epithelium + (mild multifocal) + (mild multifocal) 
Liver 
Hepatocytes + (faint diffuse) + (faint multifocal) 
Ductal epithelium + (mild multifocal) + (intense multifocal) 
+/- = mild, + = moderate, ++ = intense 
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3. Discussion 
 
The present study reports for the first time the extrahepatic expression of five APP, namely AGP, 
SAA, PIT54, CRP and OVT, in twenty tissues collected from healthy chicken. Where antibodies 
were commercially available, protein localization was also determined by immunohistochemical 
studies. Acute phase proteins mRNA was detected in all tissues included in this experiment, and 
liver was confirmed to be the main source of APP. Extrahepatic production of APP mRNA was 
found to be particularly abundant in the gastrointestinal tract, lymphatic system and lung.  
Among the five APP, SAA mRNA was found to be the most abundantly expressed. SAA is a 
major APP in vertebrates and can easily increase its concentration up to 1000-fold as response to 
a stimuli (Gabay and Kushner, 1999). SAA belongs to a family of apolipoproteins that are 
incorporated into high-density lipoprotein to be afterward released into the circulation (Benditt 
and Eriksen, 1977). In mammals, multiple SAA genes have been described (Uhlar and 
Whitehead, 1999; Upragarin et al., 2005). In chickens, on the other hand, only one SAA gene has 
been identified so far (Ovelgönne et al., 2001). SAA exhibits significant immunological activity 
being chemotactic for neutrophils and mast cells, and takes part to the so called cytokine-serum 
amyloid A-chemokine network (De Buck et al., 2016). In humans, SAA can act as pathogenic 
pattern recognition protein by opsonizing Gram-negative bacteria, increasing meanwhile 
macrophages and neutrophil phagocytosis (Shah et al., 2006). Furthermore, SAA can activate the 
inflammasome cascade (Eklund et al., 2012). Given the background of its immune-modulatory 
activity, it is not surprising that the extrahepatic tissues where SAA was found to be mostly 
expressed were those related to immune defenses, such as for example cecal tonsils, in which 
SAA mRNA abundance almost equals the amount produced by liver (0.72). This finding 
supports the hypothesis that cecal tonsil, which is the major lymphoid district within the gut-
associated lymphoid tissue (GALT) (Yun et al., 2000), is probably a second main source of SAA 
in chicken. Spleen was the other tissue where SAA was found to be abundantly expressed (0.26 
as compared with liver), in agreement with previous findings reporting splenic expression of 
SAA in chickens orally infected with S. enteritidis (Matulova et al., 2012) and Ascaridia galli 
(Dalgaard et al., 2015). The mRNA abundance of SAA in the cecal tonsils and spleen tissues 
may confirm in chicken that, as has been demonstrated in humans and laboratory rodents, SAA 
is also involved in the development of adaptive immunity, as shown by its capability to induce 
the expression of IL-17A and IL-17F from CD4+ T cells (Ather et al., 2011; 2013). This 
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hypothesis is also supported by the finding of SAA mRNA in Meckel’s diverticulum, which is 
regarded as a fully mature lymphoid tissue in chicken (Casteleyn et al., 2010). SAA mRNA 
expression was also detected in pancreas, in a similar way already reported by Lecchi et al. 
(2012) and, for the first time, in gizzard’s mucosa, which is a part of the digestive tract of birds. 
The potential presence of SAA in this district is interesting, since provides the evidence that also 
locally produced innate-immunity related proteins can protect the mucosa of the mechanical 
stomach of poultry. The last tissue where SAA was found to be highly expressed was lung (0.60 
as compared with liver). Respiratory system provides the second main entrance for many 
pathogens in mammals as well as in avian species (Smiałek et al., 2011). The finding of SAA 
expression in lung is consistent with what has been recently reported about lung and spleen SAA 
overexpression in chickens experimentally challenged with H5N1 influenza virus (Burggraaf et 
al., 2014). 
Beside SAA, also OVT was found to be heavily expressed in lungs (0.26 as compared to liver). 
The product of expression, namely the OVT protein, was also detected at the protein level by 
immunohistochemistry, identifying lungs as another important source of APP in chicken (Geus 
and Vervelde, 2013). Ovotransferrin provides an useful biomarker of inflammatory diseases in 
chicken (Rath et al., 2009), but no information about its extrahepatic expression was available 
before the present study. The high level of expression of OVT in lungs may also explain the 
early appearance of this protein in serum after experimental challenging with avian influenza 
virus (Sylte and Suarez, 2012). Ovotransferrin is a multi-functional protein with a major role in 
avian natural immunity (Giansanti et al., 2012). It was shown that OVT could permeate E.coli 
outer membrane, accessing to their inner membrane and causing ion leakage inside bacteria, 
eventually driving to the uncoupling the respiratory-dependent energy production (Aguilera et 
al., 2003). Consistently with its immune-related function, OVT mRNA was found expressed also 
in bursa of Fabricius (0.13 as compared with liver), which is a central lymphoid organ for B cells 
production and lymphocyte maturation (Ratcliffe, 2002). On the background of its distribution 
along the mucosa and the immune districts associated to gastroenteric system, we may therefore 
speculate that OVT may contribute to the first line of defense against invading pathogens. High 
expression of OVT was also detected in pancreas (0.11), pericardial adipose tissue (0.19) and 
brain (0.11). Its identification in brain suggests that OVT may fulfil its activity of iron-binding 
uptake (Taylor and Morgan, 1991) also in chicken central nervous system. We may also not rule 
out the possibility that one of OVT function in brain includes the scavenging of iron radical in 
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order to protect neural cells from reactive oxygen species damages. The physiological role of 
OVT in pancreas remains elusive.  
CRP mRNA was found to be moderately expressed in brain and visceral adipose tissue (0.06 and 
0.03 as compared to liver, respectively). CRP has the ability to bind directly to necrotic cells, 
cellular debris and polysaccharides on bacteria, fungi, and parasites, thus acting as an opsonin. In 
as such, CRP activates the complement system when bound to one of its ligands and binds to 
phagocytic cells, modulating both humoral and cellular components of inflammation (Petersen et 
al., 2004). In humans, CRP over-expression in brain and adipose tissue is associated to brain 
diseases, or metabolic disorders related to inflamed adipose tissue, respectively (Brooks et al., 
2010; Islam, 2016). The biological significance of CRP expression in these two tissues in 
chickens has yet to be elucidated. 
Although detected in all tissues included in this studies, the extrahepatic mRNA expression of 
AGP and PIT54 was found to be negligible as compared to liver (<0.01). For what concerns 
AGP, these findings look somehow contradictory if compared with immunohistochemistry 
result, since the presence of the protein was demonstrated in many tissues. This result can be 
partially explained by the long half-life of AGP after its synthesis (Ceciliani and Pocacqua, 
2007). It cannot also be ruled out the possibility that the protein found in the tissues also derive, 
at least partially, from the liver and carried out to tissues via blood circulation. 
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4. Conclusions 
 
In conclusion, the data presented here demonstrated that the five acute phase proteins AGP, 
SAA, PIT54, CRP and OVT, are constitutively expressed in all chicken tissues even in absence 
of a systemic acute phase response. The APP mRNA abundance of SAA and OVT was found to 
be higher in three systems, namely respiratory, gastrointestinal and lymphoid system. We 
confirmed the presence of AGP and OVT corresponding proteins directly in almost all tissues.  
The results presented in this study suggest the hypothesis that extrahepatic APP, in particular 
those produced at mucosal levels, might play important roles in the innate and adaptive 
immunity by providing the first line of defense against pathogens or locally modulating the 
inflammation. Probably, the locally APP production can immediately support and control the 
local defense and initiate repairs, while liver supplies vast amounts of these reactants to all body 
parts. 
Further research is needed to investigate the relationship between local and systemic reactions 
and to determine the significance of its local production in avian species. Understanding where 
APP are produced and secreted is the first step for their proper utilization as biomarkers during 
diseases. 
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5.2. The effect of transport stress on turkey (Meleagris gallopavo) 
liver and adipose tissue acute phase proteins gene expression 
 
Part of this work is already published as: 
The effect of transport stress on turkey (Meleagris gallopavo) liver acute phase proteins 
gene expression. 
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Abstract 
 
The aim of this study was to investigate the effects of transport-related stress on liver and 
adipose tissue gene expression of four acute phase proteins (APP), namely α1-acid glycoprotein 
(AGP), Serum Amyloid A (SAA), PIT54 and C-Reactive Protein (CRP) in turkey (Meleagris 
gallopavo). A group of seven BUT BIG 6 commercial hens was subjected to a 2-hour long road 
transportation and the quantitative gene expression of APP in the liver and adipose tissue was 
compared to that of a not transported control group. The expression of AGP and CRP mRNA 
was found to be increased in animals slaughtered after road transport. AGP mRNA expression 
was increased in both liver and adipose tissue, whereas CRP mRNA expression was increased in 
liver alone. The presence of AGP protein was also confirmed by immunohistochemistry and 
Western blotting. Two antibodies against CRP and PIT54 proteins were raised but their 
validation was not succeeded. The results of this study showed that road-transport might induce 
the mRNA expression of immune related proteins. The finding that AGP and CRP can be 
upregulated during transport could suggest their use as for the assessment of turkey welfare 
during transport. 
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1. Material and methods 
 
1.1. Samples collection and preservation 
Liver and visceral adipose tissue samples were collected during routinely slaughtering 
procedures from fourteen 92 day-old clinically healthy BUT BIG 6 breeding line female turkeys. 
Clinical status of the animals was verified following a clinical examination of the animals and 
the absence of evident pathologic lesions in the carcasses. 
The first group of seven animals was slaughtered and sampled in an abattoir located on site 
(control group – not transported animals), the second group of seven animals received the same 
treatment after a two hours transport (transport–stressed animals). The transport of turkeys was 
carried out on a truck that was authorized by Italian Health Institutions following the Council 
Regulation (EC) No 1/2005 of 22 December 2004 on the protection of animals during transport 
and related operations and amending Directives 64/432/EEC and 93/119/EC and Regulation 
(EC) No 1255/97). Animal were transported in plastic coop 1 m width × 60 cm length × 39"L × 
40 cm high. Temperature ranged from 20 to 22°C. Both groups underwent the same handling 
procedure (namely catching and caging and the same slaughtering procedure), with the exception 
of road-transport. 
Portions of liver and visceral adipose tissue were removed immediately after slaughtering, snap 
frozen into liquid nitrogen and afterwards stored at −80ºC (for gene expression analyses). 
Samples for immunohistochemistry analysis were fixed in 10% buffered formalin. 
 
1.2. Primers design 
The nucleotide sequences of four APP, namely AGP, SAA, PIT54 and CRP, were identified 
among the sequences available in NCBI. Primers were designed on turkey sequences available in 
NCBI by using Primer 3 (http://bioinfo.ut.ee/primer3-0.4.0), preventing possible secondary 
structures with the mfold Web Server (http://mfold.rna.albany.edu/?q=mfold/DNA-Folding-
Form) and ensuring the specificity of the sequence by Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo). Primer sequences and fragment sizes are described in 
Table 1. 
88 
 
Table 1. List of the genes under study and their respective primers sequences, accession 
numbers and fragment lengths. 
Gene GenBank Primer Forward (5’-3’) Primer Reverse (5’-3’) 
Length 
(bp) 
AGP XM_003211214 TCCCTGCCGAAATAGACAAC TCCTTCATCTCAGCCATGTG 103 
SAA XM_003206257.1 TGCTTCGTGTTGCTCTCCAT CATGTCCCGGTATGCTCTCC 123 
PIT54 XM_003202017 GCCAGTGCAATTTGTTCAGA TCCCGTAAATCCCAGTTGTC 146 
CRP EU106581.1 ATCCCATGCTCAACTTCACC CCGACGTAGAAGCGGTACTC 145 
GAPDH GQ184819.1 GATCCCTTCATCGACCTGAA ACAGTGCCCTTGAAGTGTCC 77 
RPL4 XM_003209573.1 TGTTTGCCCCAACCAAGACT TCCTCAATGCGGTGACCTTT 136 
YWHAZ XM_003205203.1 TTCCCTTGCAAAAACGGCTT TTCAGCTTCGTCTCCTTGGG 148 
AGP, alpha 1-acid glycoprotein; SAA, serum amyloid A; PIT54, scavenger receptor cysteine-rich domain-containing 
protein LOC284297 homolog (haptoglobin-like); CRP, C-reactive protein; GAPDH, glyceraldehyde 3-phosphate 
dehydrogenase; RPL4, ribosomal protein L4; YWHAZ, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein, zeta. 
 
1.3. RNA extraction and cDNA synthesis 
Total RNA was extracted using TriZol standard protocol (Invitrogen). RNA concentration and 
quality were validated as ratio A260/A280 by NanoDrop ND-1000 UV–vis spectrophotometer 
(NanoDrop Technologies Inc.). RNA was treated with DNase (Fermentas) and the first-strand 
cDNA synthesis was carried out with 1 µg RNA using iScript cDNA synthesis kit (BioRad). 
 
1.4. Qualitative mRNA expression 
The cDNA was used as template for PCRs, which were performed in 10 µL final volume 
containing 1x buffer (LeGene Biosciences), 1.5 mM MgCl2, 0.2 mM each deoxynucleotide 
triphosphate (dNTP), 1 µM each primer (Table 1) and 0.025 U Taq polymerase (LeGene 
Biosciences). PCR conditions were 35 cycles of 94ºC for 30sec, 60ºC for 30sec and 72ºC for 
45sec (Eppendorf Mastercycler). PCR products were visualized on 1.6% agarose gel stained with 
ethidium bromide. 
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1.5. Quantitative mRNA expression 
Quantitative Real Time PCR (qPCR) was performed using 12 µL Eva Green Supermix 
(BioRad), 250 nM AGP and  PIT54, 300 nM SAA and CRP and 400 nM GAPDH, YWHAZ and 
RPL4 primers, using Eco Real Time PCR detection System (Illumina). 
In order to evaluate the PCR efficiency using a relative standard curve, series of dilution were 
prepared by performing four-fold serial dilution starting from the pooled sample composed by 
liver cDNA of five not transported animals. Each sample was tested in duplicate. No-RT controls 
were performed by omitting reverse transcription and no template controls were conducted by 
adding nuclease free water. The thermal profile used was the same for each target gene: 95°C for 
10 min, 40 cycles of 95°C for 10 sec and 60°C for 30 sec; for melting curve construction, 55°C 
for 15 sec and 80 cycles starting to 55°C and increasing 0.5°C each 10 sec. The MIQE guidelines 
were followed (Bustin et al., 2009). For all genes studied, the standard curves derived from serial 
dilution of pooled sample gave correlation coefficients (R2) greater than 0.990 and efficiencies 
greater than 94%. Results were compared using the comparative ∆-∆Cq method (Giulietti et al., 
2001). 
Three housekeeping genes were selected (GAPDH, RPL4 and YWHAZ) based on previous 
studies and literature (Lecchi et al., 2012; Yang et al., 2013; Yue et al., 2010) and geometric 
mean was used for normalization purposes. 
 
1.6. Western blotting analysis 
In order to assess the cross-reactivity of turkey AGP with available anti-AGP antibodies, 
Western blotting analysis was carried out on turkey liver and adipose tissue using an anti-bovine 
AGP antibody. No antibody specific for turkey CRP, PIT54 and SAA has been reported so far in 
literature. 
Aliquots of 50 mg of liver and 100 mg of adipose tissue were mechanically homogenized in 6 
volumes (w/v) of lysis buffer (50 mM Tris-HCl pH=7.6, 150 mM NaCl, 5 mM EDTA, 4% 
IGEPAL (NP-40), 1% Triton X-100, 1% Zwitterion) added with a protease inhibitors cocktail 
(1:100) (Sigma Aldrich) and incubated for 1 h on ice. After incubation, aliquots were centrifuged 
at 14000 x g for 15 min at RT. For adipose tissue, an extra centrifugation was done at 14000 x g 
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for 10 min at RT. The protein content of the supernatant was then quantified at 280 nm by 
JASCO Model V-530 UV-vis Spectrophotometer (JASCO Inc.). 
A total of 100 µg (liver) and 150 µg (adipose tissue) total protein were separated on a 12% 
sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS–PAGE) and blotted onto 
nitrocellulose membrane. Before gel separation, 1 µl ß-mercaptoethanol (Sigma Aldrich) was 
added to each sample. Immunolabeling was performed using a rabbit polyclonal anti-bovine 
AGP (Ceciliani et al., 2007) as primary antibody (1:4000 dilution for 1 h min at RT), while an 
anti-rabbit IgG labelled with peroxidase (Vector Laboratories) was used as secondary antibody 
(1:4000 dilution for  45 min at RT). A purified AGP from bovine (1 µg/µL) was used as positive 
control. Immunoreactive bands were visualized by enhanced chemiluminescence (ECL) using 
Immobilon Western Chemiluminescent HRP Substrate (Millipore). A purified AGP from bovine 
serum (1 µg/µL) was used as positive control (Ceciliani et al., 2005). 
In order to further assess the specificity of the primary antibody, the Western blotting experiment 
was repeated after overnight incubation of bovine anti-AGP antibody (Ceciliani et al., 2007)  
coupled with bovine AGP (Ceciliani et al., 2005) using a 1:10 molar ratio, in order to block 
every anti-AGP specific reactive sites and to detect any possible non-specific reactions. The 
solution was then utilized as primary antibody in immunolabeling detection procedure (1:4000 
dilution  for  1 h  at  RT). 
 
1.7. Immunohistochemistry studies 
Immunolocalization in liver was carried out as previously described (Rahman et al., 2015). 
Briefly, immunohistochemistry was performed on fixed in 10% buffered formalin and embedded 
in paraffin tissue sections to identify AGP in the different cell types present in liver and adipose 
tissue. Sections of 5 µm thick were obtained and mounted on poly-lysine-coated slides.  
The sections were deparaffinized in xylene and rehydrated through a descending series of 
ethanol concentrations. The endogenous peroxidase activity was blocked with 0.3% H2O2 in 
methanol for 30 min. Antigen retrieval was then performed by heating the slides in a pressure 
cooker for 10 min at 95ºC in citrate buffer solution (pH=6.5). The sections were cooled for 40 
min at RT and then rinsed in Tris buffered saline (TBS). The slides were then incubated for 20 
min at RT with normal goat serum (1:70) to block any nonspecific protein binding. After 
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incubation with the same primary antibody used for Western blotting at a dilution of 1:200 for 
anti-bovine AGP (Ceciliani et al., 2007), the slides were incubated at 4°C overnight in a 
humidified chamber. 
The sections were rinsed in TBS for 3 times of 5 min each and treated with PolyView 
mouse/rabbit nanopolymer detection reagents (Enzo Life Sciences) for 20 min at RT. After three 
washes in TBS, the chromogen, 3-amino-9-ethylcarbazole (Vector Laboratories), was applied for 
20 min. The slides were then rinsed in tap water, counterstained with Mayer hematoxylin 
(Diapath srl) for 1 min and mounted with glycerine jelly (Kaiser’s glycerol gelatine, Merck).  
Negative controls were prepared by replacing the respective primary antibody with normal rabbit 
serum (non-immune rabbit serum, Dakocymation). In addition, to rule out unspecific cross-
reactivity of the antibodies included in this study the anti-AGP specific sites were blocked by 
pre-incubation with bovine purified AGP, prior to IHC as previously described (Ceciliani et al., 
2005; Rahman et al., 2010). 
 
1.8. Anti-CRP and anti-PIT54 antibodies production and validation 
CRP and PIT54 protein sequence from turkey and chicken were aligned against CRP and Hp 
rabbit sequences. Two small peptides composed by 15 amino acids 100% conserved between 
turkey and chicken species, but not between poultry and rabbit, were selected (Table 2). The 
peptides were synthesize as Multiple Antigen Presentation (MAP) technique. Using a BlastP 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi), the new designed peptides were confirmed not have 
homology with rabbit. 
Four rabbits were inoculated with new produced peptides. Two rabbits were inoculated with 
CRP peptide and two rabbits were inoculated with PIT54 peptide. Blood was collected from the 
animals after a two months period and antibodies were purified by affinity chromatography using 
the respective peptide as column ligands. This part of the project was carried out in cooperation 
with the group of Biochemistry of the department, with the support of Dr. Vitaliano Borromeo 
and Dr. Anna Berrini. 
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Table 2. CRP and PIT54 peptide sequence from turkey and chicken. 
Protein name Peptide sequence 
CRP YVTFRVPENRGEWE 
PIT54 ALGGARYGRGPDVIW 
CRP, C-reactive protein; PIT54, scavenger receptor cysteine-rich domain-containing protein 
LOC284297 homolog (haptoglobin-like). 
 
Reactivity between new produced antibodies against CRP and PIT54 turkey and chicken proteins 
was validated by Western blotting analysis. Serum from turkey and chicken were separated on a 
12% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and blotted onto 
nitrocellulose membrane. Immunolabeling was performed using the new produced rabbit 
polyclonal anti-CRP and anti-PIT54 antibodies as primary antibody (1:2000 and 1:1000 
dilutions, respectively, for 2 h at RT), while a goat anti-rabbit IgG with peroxidase (Vector 
Laboratories) was used as secondary antibody (1:10000 dilution for 45 min at RT). CRP and 
PIT54 peptides (0.05 µg/µL) were used as positive control.  
The specificity of the primary antibodies was confirmed after overnight incubation of anti-CRP 
and anti-PIT54 antibodies coupled with CRP and PIT54 peptides, respectively, using a 1:10 
molar ratio, in order to block every anti-CRP and anti-PIT54 specific reactive sites. The solution 
was then utilized as primary antibody in immunolabeling detection procedure (1:2000 dilution 
for 2 h at RT). 
 
1.9. Statistical analysis 
Statistical analysis was performed using a General Linear Model procedure of SAS (SAS version 
9.2 Inst. Inc., Cary, NC). Least significant difference was used to compare mean values. 
Statistical significance was accepted at p-value ≤ 0.05. 
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2.5. The localization of AGP in turkey liver and adipose tissue 
An anti-AGP positive immunostaining was detected in liver and adipose tissue. Results are 
presented in Figure 6.  
In hepatocytes (Figure 6A), anti-AGP positive intracytoplasmic finely granular immunostaining 
(red staining) was multifocally detected. Positive signal was not diffuse and small groups of 
positive hepatocytes were scattered throughout the liver parenchyma, without any evident 
pattern.  
In adipose tissue section (Figure 6B), anti-AGP stained an elevated number of adipocytes. 
Specifically, anti-AGP immunostaining was localized at the periphery of adipocyte cytoplasm, 
lining cell borders. Immunostaining was not detected in adipose tissue fibrous septa nor in 
vessels. 
As already demonstrated during Western blotting experiments, the positive immunolabeling of 
control and fat tissues completely disappeared when tissue sections were stained with the pre-
blocked antibodies, confirming the specificity of anti-AGP antibody for its antigen on tissues as 
well. No immunostaining was observed in negative control samples. 
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Figure 7. Example of Lys-based Multiple Antigen Presentation (MAP) vaccines (Fujita and Taguchi, 
2011). 
 
After purification, 1.5 ml of anti-CRP antibodies with a concentration of 1.14 mg/ml and 0.858 
mg/ml, and 2 ml of anti-PIT54 antibodies with a concentration of 0.629 mg/ml and 0.387 mg/ml 
were obtained. The validation of newly produced antibodies was checked by Western blotting 
that was shown a very similar pattern for both anti-CRP and anti-PIT54 antibodies, reacting with 
a band with a MW of 26 kDa and a block of bands with a MW range of 50–75 kDa (Figure 8). 
CRP individual subunits have approximately 24 kDa, whereas the MW of the entire molecule is 
120 kDa (Thiele et al., 2015). Members of the PIT54 family were previously identified as a 
single peptide, with a molecular size of 54 or 66 kDa in the absence or presence of 2-
mercaptoethanol (Iwasaki et al., 2001). 
As negative control, anti-CRP and anti-PIT54 antibodies specific sites were blocked with CRP 
and PIT54 peptides before using them as primary antibody. A very strong attenuation of the 
signal for both anti-CRP and anti-PIT54 antibodies was obtained, thus confirming that antibodies 
are binding specifically (Figure 9). 
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3. Discussion 
 
The present study provides, for the first time, information about acute phase protein in turkey. 
We have demonstrated that 2h-long road transportation is capable to modify AGP and CRP 
mRNA liver expression. Remarkably, adipose tissue was also found to be reactive to road 
transportation, since AGP mRNA abundance has also increased in transport–stressed animals. 
The effective presence of the AGP protein was confirmed by Western blotting and 
immunohistochemistry. Western blotting electropherogram clearly identified in liver and adipose 
tissue a 55–66 kDa band, with the same molecular weight of the corresponding bovine AGP 
(Rahman et al., 2015). 
AGP is one of the most widely measured APP in chicken (O'Reilly and Eckersall, 2014) and its 
expression has been found to be related with depressive disorders and stress in humans (Healy et 
al., 1991). AGP belongs to the family of lipocalins, e.g. binding proteins which also fulfil 
immune-modulatory function, including inhibition of phagocytosis (Lecchi et al., 2013), 
neutrophil degranulation, chemotaxis and respiratory burst (Lecchi et al., 2008; Miranda-Ribera 
et al., 2010; Rinaldi et al., 2008) and monocyte apoptosis (Ceciliani et al., 2007). The 
immunomodulatory activity of AGP is focused on dampening the side effects of inflammation. 
Given that AGP mRNA was found to be statistically significantly overexpressed in both liver 
and adipose tissue, AGP was identified as one of the major acute phase proteins in turkey, at 
least for what concerns stress measurement after road transport. This conclusion is supported by 
previous studies in chicken, which demonstrated that measurement of AGP titration could 
provide useful information on both health and welfare of laying hens reared in different housing 
systems, which were subject to stressful events (Salamano et al., 2010). The serum concentration 
of AGP was also significantly increased in organically produced broilers as compared to 
conventionally produced ones (Tuyttens et al., 2008). 
Liver function is strongly influenced by circulating glucocorticoid levels, and gene array studies 
have shown that hepatic response follows acute stress in chicken (Désert et al., 2008). A recent 
study (Sherlock et al., 2012) determined the differential hepatic gene expression in broilers in 
response to combined stressors (feed withdrawal, catching and transport), identifying 733 genes 
which were differently expressed but the use of APP as biomarkers for transport stress in poultry 
has not been adequately addressed so far. On the background that corticosteroids can upregulate 
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AGP gene expression (Ceciliani and Pocacqua, 2007), it can be therefore speculate that the 
overexpression of AGP in liver is induced by the increase of cortisol concentration induced by 
transport-related procedures. 
Among the other APP included in the present study, only liver CRP mRNA was shown to be 
upregulated (3.5-folds higher) in transport–stressed animals as compared with control. CRP is a 
major APP in humans and dogs and frequently used in veterinary field (Eckersall and Bell, 
2010), but little evidence is available in poultry (O'Reilly and Eckersall, 2014) and none in 
turkey. Although Sohail et al. (2010) found that CRP serum concentrations increased in chicken 
exposed to a heat stress conditions, and a very recent study correlated CRP concentration with 
the intensity of inflammatory reaction after Salmonella typhimurium LPS treatment (Rauber et 
al., 2014), the use of CRP as an APP in chicken is yet to be established. The present results are 
encouraging, and provide for the first time clues that CRP is related to stress induced by road 
transport in turkey.  
Neither PIT54 nor SAA liver mRNA abundance was modified after road transport, confirming in 
turkey what has already been demonstrated in chicken (Garcia et al., 2009; Georgieva et al., 
2010), that the use of PIT54 and SAA as biomarkers for diseases or welfare deserves further 
investigations, since they probably need a more intense challenge than that provided in this 
study. 
In the second part of this study, the measurement of mRNA abundance of the four candidate 
APP was extended to the visceral adipose tissue. Adipose tissue is a loose connective tissue that, 
beside its role in regulating metabolism and innate immunity, is also linked to hypothalamic-
pituitary-adrenal axis and stress (Bose et al., 2009; Chrousos, 2000). Adipose tissue affects a 
wide variety of body functions by actively secreting messenger molecules, called as 
“adipokines”, which include hormones, chemokines, cytokines and also acute phase proteins in 
both humans and farm animals (Sauerwein et al., 2014). Adipose tissue is also extremely reactive 
and sensitive to stress conditions (Charmandari et al., 2005). In previous works, AGP and SAA 
expression has been reported in different adipose tissue depots in cattle (Ceciliani et al., 2015; 
Rahman et al., 2015). The findings of this work presented the evidence that turkey visceral 
adipose tissue can produce mRNA of all four APP included in this experiment, albeit at lower 
levels as compared to liver (0.01 – 2%), and that road transport induces an overexpression of 
AGP in a statistically significant way. Moreover, the increase of mRNA abundance of  PIT54 is 
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very close to the statistical significance (p-value = 0.0806), a value that probably can be 
improved in further studies increasing the number of animals. 
PIT54 is homologous to the scavenger receptor cysteine-rich family of proteins and has been 
identified as the major hemoglobin-binding protein – haptoglobin in mammals – in chicken and 
goose plasma (Quaye, 2008; Wicher and Fries, 2006). Remarkably, PIT54 mRNA abundance 
was found to be increased only in adipose tissue and not in liver. The mammalian equivalent 
protein, haptoglobin, ranks high in the list of possible stress biomarkers in pigs (Piñeiro et al., 
2007; Soler et al., 2013), but the present findings can confirm in turkey that only adipose tissue 
PIT54 mRNA is overexpressed after transport. The impact of PIT54 and AGP production from 
adipose tissue on the overall amount of circulating protein is unknown and deserves further 
investigation. 
Previous studies on cattle, pigs and rats suggest that SAA may be used as marker of stress (Deak 
et al., 1997; Hicks et al., 1998; Lomborg et al., 2008; Soler et al., 2013) but in the current study 
no statistical increase of SAA mRNA abundance was observed, neither in liver nor in adipose 
tissue. 
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4. Conclusions 
 
In conclusion, the present study provides information on acute phase proteins in turkey, not 
available until now. On the background of mRNA abundance data, the concentration of AGP and 
CRP might be modified in turkey after road transport and may provide useful clinical indicators 
of stress in poultry. Although encouraging, these results must be considered as preliminary, and 
need to be paralleled by the measurement in serum of the respective transcript product, in order 
to confirm that AGP and CRP protein are overexpressed after road transportation and that its 
serum concentration can provide a suitable measure of turkey welfare. 
We have also demonstrated that adipose tissue is capable to mount a local acute phase response 
during a stress condition such as road transportation, through the increase expression of AGP and 
PIT54 mRNA.  
We tried to develop antibodies against poultry CRP and PIT54; however antibodies produced 
were not specific. 
Further research is needed to refine the use of these measures in the assessment of turkey 
welfare. However, the present results will pave the way for the development of turkey specific 
assays, where AGP, CRP and PIT54 might be explore as suitable biomarkers of transport stress. 
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5.3. Circulating extracellular miR-22, miR-155, and miR-365 as 
candidate biomarkers to assess transport-related stress in turkey 
(Meleagris gallopavo) 
 
This work is already published as: 
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Abstract 
 
MicroRNA (miRNA) have been identified in circulating blood and might have the potential to be 
used as biomarkers for several pathophysiological conditions. To identify miRNA that are 
altered following stress events, turkeys (Meleagris gallopavo) were subjected to 2h of road 
transportation. The expression levels of five circulating miRNA, namely miR-22, miR-155-5p, 
miR-181a-3p, miR-204 and miR-365-3p, were detected and assessed by quantitative polymerase 
chain reaction using TaqMan® probes, as potential biomarkers of stress. The areas under the 
receiver operating characteristic curves were then used to evaluate the diagnostic performance of 
miRNA. A panel of three stress-responsive miRNA, miR-22, miR-155 and miR-365 were 
identified; their expression levels were significantly higher after road transportation and the area 
under the curve (AUC) were 0.763, 0.71 and 0.704, respectively. Combining the three miRNA, a 
specificity similar to the one found for the three miRNA separately was found. The AUC of the 
weighted average of the three miRNA was 0.763. This preliminary study suggests that the 
expression levels of circulating miR-22, miR-155 and miR-365 are increased during transport-
related stress and that they may have diagnostic value to discriminate between stressed- and 
unstressed animals. 
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1. Material and methods 
 
1.1. Samples collection and preservation 
Blood was collected from sixteen clinically healthy 105-day-old turkeys BUT BIG 6 by 
branchial vein venipuncture using serum collection tubes during routine disease testing. After a 
2h road transportation, further blood samples were collected during routine slaughtering process 
from the neck vessels cut by the automatic processing killer. Road-transport was carried out 
according to EU procedures for animal transport (Council Regulation (EC) No 1/2005 of 22 
December 2004 on the protection of animals during transport and related operations and 
amending Directives 64/432/EEC and 93/119/EC and Regulation (EC) No 1255/97). Serum was 
stored at −80°C until RNA extraction. 
 
1.2. miRNA extraction and reverse transcription 
Total RNA was extracted using miRNeasy Serum/Plasma Kit (Qiagen). Serum was thawed on 
ice and centrifuged at 3000 × g for 5 min at 4°C. An aliquot of 150 µl per sample was transferred 
to a new tube and 1 ml of Qiazol was added. The Caenorhabditis elegans miRNA cel-miR-39 
(Qiagen) was used as synthetic spike-in control due to lack of sequence homology to avian 
miRNA. After an incubation at RT for 5 min, 3.75 µl (25 fmol final concentration) of spike-in 
control was added and the samples vortexed to ensure complete mixing. The RNA extraction 
was then carried out according to manufacturer’s instruction. 
Total RNA concentration and quality were validated as ratio A260/A280 by NanoDrop ND-1000 
UV–vis spectrophotometer (NanoDrop Technologies Inc.). The reverse transcription was 
performed using the TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems) using 
miRNA-specific stem-loop RT primers as according to manufacturer’s instructions. Reverse 
transcription reactions were performed in 15 µl volume reactions containing 1.5 µl 10× miRNA 
RT buffer, 1 µl MultiScribe reverse transcriptase (50 U/µl), 0.30 µl 100 mM dNTP mix, 0.19 µl 
RNase Inhibitor (20 U/µl), 6 µl of custom RT primer pool and 3.01 µl of nuclease-free water. 
The custom RT primer pool was prepared combining 10 µl of each individual 5× RT primer in a 
final volume of 1000 µl; the final concentration of each primer in the RT primer pool was 0.05× 
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each. Serum RNA of 3 µl were added to each RT reaction. RT reaction mixture were incubated 
on ice for 5 min, 16°C for 30 min, 42°C for 30 min and then 85°C for 5 min. 
 
1.3. Quantitative Real Time PCR 
The qPCR experiments were designed following MIQE guidelines (Bustin et al., 2009). Small 
RNA TaqMan assays were performed according to manufacturer’s instruction. The selected 
primer/probe assays (Life Technologies) included cel-miR-39-3p (assay ID000200), hsa-miR-22 
(assay ID398), hsa-miR-155-5p (assay ID479), hsa-miR-181a-3p (assay ID516), hsa-miR-204 
(assay ID508), hsa-miR-365-3p (assay ID1020) (Table 1). Quantitative reactions were performed 
in duplicate in scaled-down (12 µl) reaction volumes using 6 µl TaqMAN 2X Universal Master 
Mix II (Applied Biosystems), 0.6 µl miRNA specific TaqMan Assay 20× and 1 µl of the RT 
product per reaction on Eco Real Time PCR detection System (Illumina). The standard cycling 
program was 50°C for 2 min, 95°C for 10 min and 40 cycles of 95°C for 15 sec and 60°C for 60 
sec. Data were normalized relative to the expression of cel-miR-39. miRNA expression levels 
are presented in terms of fold change normalized to cel-miR-39 expression using the formula 2-
∆∆Cq (Giulietti et al., 2001). 
 
Table 1. List of the probe assays and their respective primers sequences and references. 
Assay Name Mature microRNA Sequence References 
cel-miR-39-3p UCACCGGGUGUAAAUCAGCUUG Roberts et al., 2014 
hsa-miR-22 AAGCUGCCAGUUGAAGAACUGU Wang et al., 2014 
hsa-miR-155 UUAAUGCUAAUCGUGAUAGGGG Yao et al., 2013 
hsa-miR-181a ACCAUCGACCGUUGAUUGUACC Wang et al., 2014 
hsa-miR-204 UUCCCUUUGUCAUCCUAUGCCU Ahanda et al., 2014; Wang et al., 2014 
hsa-miR-365 UAAUGCCCCUAAAAAUCCUUAU Ahanda et al., 2014 
cel-miR-39-3p, assay ID000200; hsa-miR-22, assay ID398; hsa-miR-155-5p, assay ID479; hsa-miR-181a-3p, assay ID516; 
hsa-miR-204, assay ID508; hsa-miR-365-3p, assay ID1020. 
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1.4. Statistical analysis 
Normality of the distribution of each of the miRNA variables was assessed using Shapiro–Wilk 
test. Since data were not normally distributed a non-parametric method, the Wilcoxon test, was 
used in the analysis of differences in miRNA expression. A receiver operating characteristic 
(ROC) curve was used to determine the sensitivity and specificity of the assay in discriminating 
between pre- and post-transported animals. The area under the curve (AUC) for the ROC curves 
was calculated. Statistical analysis was performed using XLSTAT for Windows (Addinsoft) and 
MedCalc 14.0 (MedCalc Software bvba). 
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2. Results 
 
2.1. miR-22, miR-155 and miR-365 levels are elevated in the blood serum of 
stressed turkeys  
The expression of miR-22, miR-155, miR-181a, miR-204 and miR-365 was quantified by qPCR 
after normalization against miRNA cel-miR-39 (Qiagen). The comparative analysis 
demonstrated that three circulating miRNA, namely miR-22, miR-155 and miR-365, were 
differentially expressed in serum samples collected after road transportation as compared with 
those collected before transportation on the same animals. 
In detail, the levels of miR-22, miR-155 and miR-365 were significantly higher after road 
transportation (all p-value < 0.05) (Figure 1). The median expression levels of miR-22, miR-155 
and miR-365 were 0.90 (range, 0.22 to 7.90), 0.97 (range, 0.43 to 2.23) and 0.66 (range, 0.27 to 
1.00) before transportation, and 1.81 (range, 0.19 to 30.13), 1.61 (range, 0.57 to 4.07) and 1.59 
(range, 0.23 to 5.76) after transportation, respectively. 
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Figure 1. Circulating stress-related miRNA levels of turkeys before and after road transportation. Levels 
of (a) miR-22, (b) miR-155, (c) miR-181a, (d) miR-204 and (e) miR-365. The black lines mark the 
median expression levels. *p-value < 0.05; **p-value < 0.01. 
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2.2. Diagnostic performance of miR-22, miR-155 and miR-365 
The potential use of the three miRNA, which were found to be differentially regulated as 
biomarker predictors of transport-related stress, was explored. Receiver-Operating Characteristic 
(ROC) analysis was used to estimate the diagnostic value of miR-22, miR-155 and miR-365, as 
well as the combination of the three miRNA. 
In statistics, a ROC curve is a graphical plot that illustrates the performance of a test. It creates a 
curve by plotting the true positive rate, called sensitivity, against the false positive rate which is 
calculated through the expression 1 - specificity. The sensibility is the probability of our test give 
us a positive result and the animal is stressed, whereas the specificity is the probability of our test 
give us a negative result and the animal is not stressed. A test with perfect discrimination has a 
ROC curve that passes through the upper left corner (100% sensitivity, 100% specificity) with no 
overlap in the two distributions. 
The area under the curve, also referred as AUC, can quantify the ability of the test to 
discriminate between stressed and not-stressed animals. A perfect test has an area about 1, and a 
bad test has an area about 0.5. Above 0.7, we consider that a test has the ability to differentiate 
both groups. It is difficult to have a sensibility and specificity both at 100%, so we selected a cut-
off with a good balance between them. 
The ROC analysis was carried out by plotting the true positive (sensitivity) versus false positive 
(1-specificity). Cut-off points were set in order to maximize the sum of sensitivity and 
specificity. The cut-off points for miR-22, miR-155 and miR-365 were 1.31, 1.48 and 1.59, 
respectively (Table 2). The diagnostic accuracy of miR-22, miR-155 and miR-365, as measured 
by the area under the curve (AUC) and it was 0.763 (95% CI 0.586 to 0.941), 0.710 (95% CI 
0.512 to 0.908) and 0.704 (95% CI 0.497 to 0.912), respectively (Figure 2). 
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Table 2. Cut-off, sensitivity, specificity and AUC for each candidate miRNA and for their 
combination. 
Stress marker Cut-off Sensitivity (%) Specificity (%) AUC (95% CI) 
miR-22 1.31 76.9 76.9 0.763 (0.586 – 0.941) 
miR-155 1.48 61.5 92.3 0.710 (0.512 – 0.908) 
miR-365 1.59 53.8 100 0.704 (0.497 – 0.912) 
miR-22, miR-155, miR-365 2.131 69.2 84.6 0.763 (0.557 – 0.906) 
hsa-miR-22, assay ID398; hsa-miR-155-5p, assay ID479;hsa-miR-365-3p, assay ID1020. 
 
 
Figure 2. Receiver-operator characteristics (ROC) curve analysis of candidate stress-related miRNA. 
ROC plots for (a) miR-22, (b) miR-155 and (c) miR-365 were used to differentiate stressed from not-
stressed animals. AUC, area under the curve; CI, confidence interval. 
 
Further statistical analysis was performed considering the weighted average relative 
quantification values of the three stressed-related miRNA. The median expression levels were 
1.02 (range, 0.62 to 1.38) and 1.97 (range, 1.73 to 6.26) before and after transportation, 
respectively (Figure 3a). 
The logit model based on the three miRNA [logit= (0.065 x expression level of miR-22) + (0.562 
x expression level of miR-155) + (1.395 x expression level of miR-365)] was used to assess the 
predicted probability of being discriminated as stressed-animals and to construct a ROC curve 
(Figure 3b). The AUC for the combined miRNA was 0.763 (95% CI 0.557 to 0.906) (Table 2) 
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and suggests that serum levels of miR-22, miR-155 and miR-365 can discriminate transported 
from not-transported animals alone or in combination. 
 
 
Figure 3. The average expression of the three candidate stress-related miRNA. (a) The weighted average 
relative quantification levels of miR-22, miR-155 and miR-365 before and after road transportation. The 
black lines mark the median expression levels. * p-value< 0.05. (b) Receiver operating characteristics 
(ROC) curve analysis of miR-22, miR-155 and miR-365, constructed using the logit model. AUC, area 
under the curve; CI, confidence interval. 
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3. Discussion 
 
Five miRNAs, previously demonstrated to be related to stressful events in chicken and immune 
defenses, were selected for our study – miR-22, miR-155, miR-181a, miR-204 and miR-365. 
MiR-22 is involved in hypothalamic fear and stress response in chicken after tonic immobility 
(Wang et al., 2014). MiR-155 is conserved between many species and it was found to play 
critical roles in various physiological and pathological processes such as immunity in chicken 
(Mashima, 2015; Yao et al., 2013). MiR-181a is studied in farm animals and seems to be related 
with immunity and stress in chicken (Wang et al., 2013; Wang et al., 2014). MiR-204 and miR-
365 are related with feed deprivation stress in chicken (Ahanda et al., 2014). 
The present work provided the evidence that three miRNA, namely miR-22, miR-155 and miR-
365, initially chosen as regulation members of innate immunity, are upregulated in a statistically 
significant way during road transport. Moreover, ROC analysis demonstrated that the 
combination of the three miRNA which were found upregulated may be regarded as a potential 
diagnostic biomarker panel to determine transport-related welfare in turkey species. 
Accurate determination of stress in poultry, and farm animals in general, is critical, since it is 
often difficult to measure quantitatively stress-related parameters. Beside the use of behavioural 
scoring system, biochemical parameters have been proposed to provide a broad assessment of 
animal welfare including corticosteroids and acute phase proteins (Marchewka et al., 2013; 
Piñeiro et al., 2007). MiRNA have been identified in animal species as biomarkers (Wang et al., 
2013) and they can be easily extracted from extracellular body fluids (Gilad et al., 2008; Roberts 
et al., 2014). The modulation of miRNAs expression is also an early event in stressful conditions 
(Biggar and Storey, 2015; Emde and Hornstein, 2014; Leung and Sharp, 2010).  
The hypothesis of this study was that circulating miRNA could provide a useful source of 
biomarkers for objective measurements of animal welfare. This hypothesis was validated by 
demonstrating that three miRNA (from five selected miRNA) were significantly upregulated 
during road transport in turkeys. Given their involvement in stressful events and modulation of 
immune response (Ahanda et al., 2014; Mashima, 2015; Wang et al., 2014), the present results 
suggest that transport-related procedures may interfere with the immune status of the animals by 
modifying the gene expression level of immune-related miRNA. 
118 
 
MiRNA act as regulators of gene expression during many different pathophysiological pathways, 
including those involved in neuropsychiatric disorders and stress (Kocerha et al., 2015), 
moreover a recent study reported that miRNome is capable of quickly reacting to feed 
deprivation stress in chicken (Ahanda et al., 2014). 
In particular, miR-155 is physiologically expressed at low levels in B and T cells, macrophages, 
dendritic cells, and progenitor/stem cell populations, and is upregulated after their activation by 
immune stimuli, evading to modulation of humoral and innate cell-mediated immune responses 
(Elton et al., 2013).  
MiR-22 is one of the very few ubiquitously expressed miRNA, and is likely to be involved in 
buffering cellular activities that are common to the vast majority cells. Among others activities, 
it is involved in the hematopoiesis process, in the down regulation of IL6 and in the 
differentiation of Th17 cells (Liang et al., 2015).  
The role of miR-365 is still not well understood. MiR-365 expression has been so far associated 
to cancer development and its progression (Zhou et al., 2013). The finding that miR-365 may be 
related to transport-stress confirms what has been recently reported by Ahanda et al. (2014), who 
demonstrated that miR-365 family members are present in plasma and red blood, but not white 
blood cells, and their expression is modulated by food deprivation stress. 
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4. Conclusions  
 
In conclusion, this preliminary study highlighted that transport-related procedures are capable of 
modifying expression of immune-related miRNA, providing for the first time a molecular link 
between stress and immune defenses in turkey species. 
In the second part of this investigation, we demonstrated by ROC analysis that miR-22, miR-155 
and miR-365, individually or in combination, may be useful to discriminate between stressed- 
and not-stressed animals.  
In order to confirm the diagnostic value of these candidate miRNA, and develop a minimally 
invasive screening tool for assessing turkey welfare, further studies on a higher number of 
samples and different transport conditions are required to validate the candidate miRNAs in the 
field. 
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5.4. Proteome analysis of intestinal mucosa in turkey (Meleagris 
gallopavo) infected with haemorrhagic enteritis virus 
 
Manuscript of this work is already in preparation to be submitted to Journal of Proteomics: 
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Abstract 
 
Haemorrhagic enteritis (HE) is a viral disease, which negatively affects intestinal integrity and 
barrier function in turkey (Meleagris gallopavo). Birds exhibit HEV-induced 
immunosuppression condition and can easily be infected with secondary infections agents, 
resulting in significant economic loss. To our best knowledge, intestinal proteome studies is 
turkey have not been presented yet. Therefore, this study integrate a proteomic approach to 
investigate the effects of HE disease on intestinal mucosa, focusing on proteins involved in 
immunity and inflammatory pathways. A total of 523 unique proteins were identified by 
SWATH-MS strategy between healthy and HEV-affected intestine. Sixty-four intestinal mucosa 
proteins were found to be differentially abundant. Twenty-two of them are related to energy 
metabolism, 16 with protein metabolism, 7 with cytoskeleton, and their changes in abundance 
could comprise intestinal integrity and function. The up-regulation of proteins involved in 
carbohydrate metabolism, fatty acids metabolism and oxidative phosphorylation suggested that 
HE disease disturbs energy metabolism and thus induce oxidative stress. We also found seven 
proteins related with immune system, all of them up-regulated in HEV-affected intestine. A 
qualitative PCR further confirmed the individual mRNA presence for six of these proteins. These 
findings have important implications for understanding the effect of HE in turkeys. 
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1. Material and methods 
 
1.1. Samples collection and preservation 
Samples were obtained during routinely slaughtering procedures from 92-day-old females BUT 
BIG 6 breeding line female turkeys. A group of four turkeys were clinical healthy and PCR HEV 
negative (control group). A second group of four turkeys were PCR HEV positive (HEV-
infected animals). Clinical status of the animals was also assessed by ante- and post-mortem 
inspection. 
Portions of intestine were removed immediately after slaughtering, mucosa was scratched, snap 
frozen into liquid nitrogen and afterwards stored at −80ºC. 
 
1.2. Protein extraction 
Protein extraction of intestinal mucosa was carried out on ice, following a general protocol for 
lysis of cells with 2X lysis buffer. In short, 400 mg of each tissue was washed with cold PBS, 
traces of blood were removed and tissue was homogenized in 1 ml lysis buffer (50 mM Tris pH 
7.4, 150 mM NaCl, 1% Triton X-100, 1% IGEPAL (NP-40), 0.1% SDS) with 10 µl Protease 
Inhibitor Cocktail (Sigma-Aldrich). Tissue disruption was performed using a tissue homogenizer 
(Precellys24, Bertin Technologies) (4 cycles, 5500 rpm, 20 sec) and glass beads (0.1 mm, Bertin 
Technologies) and sonicated on ice (10 cycles, 10 sec). Protein extracts were centrifuged for 10 
min, 10000 x g, 4°C. Supernatant containing protein extract was stored at –80°C until prior use. 
Protein concentration was determined using the method of Bradford (1976) with bovine serum 
albumin (BSA) as a protein standard. BSA solution was prepared in PBS 1x with a concentration 
of 2 mg/ml. A series of protein solutions were prepared by serial dilution. The absorbance was 
measured at 610 nm using Odyssey® CLx Infrared Imaging System (LI-COR, Biosciences). The 
concentration of protein was plotted against the corresponding absorbance resulting in a standard 
curve, which was used to determine the protein content (R2=0.9964). 
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1.3. Protein digestion 
Protein extracts were hydrolyzed in-solution, essentially as described in Llombart et al. (2015). 
Samples were adjusted to a concentration of 2 µg/µL with 6 M Urea and 50 mM NH4HCO3 
pH=8.5. Two µg of green fluorescence protein (GFP) was used as internal standard for each 
sample. Reduction was performed by addition of dithiothreitol (DTT) at a concentration of 10 
mM and incubated for 1 h at RT. As alkylating agent, iodoacetamide (IAA) was used at a 
concentration of 30 mM and incubated for 30 min at RT in the dark. IAA was quenched by 
adding N-Acetyl-L-cysteine (NAC) at a concentration of 37.5 mM and incubated for 15 min at 
RT. Urea concentration was lowered to 1 M by adding 50 mM NH4HCO3 pH=8.5. Finally, 
samples were digested with trypsin (Promega) (trypsin:protein=1:20, w/w) for 18 h at 37 °C and, 
afterwards, the reaction was stopped by addition of 0.5% formic acid (FA). 
 
1.4. Sample preparation for LC-MS/MS 
The digested peptides were de-salted and concentrated using C18 Bond Elut OMIX solid phase 
extraction pipette tips (Agilent Technologies) as described in Silva et al. (2016). Each mixture 
was completely dried and then re-suspended in 100 µl of 2% acetonitrile (ACN) with 1% FA and 
sonicated in the ultrasound bath for 5 min with low amplitude. The tip column was hydrated with 
100 µL of 50% ACN and equilibrated with 100 µL of 2% ACN with 1% FA. The peptides were 
loaded into the column five times followed by a wash step with 100 µL of 2% ACN with 1% FA. 
Peptides were then eluted with 100 µL of 70 % ACN with 0.1 % FA and after evaporation the 
pellets were stored at –20ºC until LC-MS/MS analysis. 
The washed pellets were resuspended in 50 µL of a solution of 2% ACN and 0.1% FA, and 10 
µL of each replicate (in a total of 4 replicates per condition) were used to create a pooled sample 
for protein identification. In order to remove insoluble material, the peptide mixture were then 
centrifuged for 5 min at 14000 x g and collected into the proper vial for LC-MS injection. 
 
1.5. LC-MS/MS analysis 
Samples were analyzed on a Triple TOFTM 5600 System (ABSciex®) in two phases: 
information-dependent acquisition (IDA) of the pooled samples and, SWATH (Sequential 
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Windowed data independent Acquisition of the Total High-resolution Mass Spectra) acquisition 
of each individual sample. Peptides were resolved by liquid chromatography (nanoLC Ultra 2D, 
Eksigent®) on a MicroLC column ChromXPTM C18CL (300 µm ID × 15 cm length, 3 µm 
particles, 120 Å pore size, Eksigent®) at 5 µL/min with a multistep gradient: 0-2 min linear 
gradient from 2 to 5%, 2-45 min linear gradient from 5 % to 30 % and, 45-46 min to 35 % of 
ACN in 0.1 % FA and 5% DMSO. Peptides were eluted into the mass spectrometer using an 
electrospray ionization source (DuoSprayTM Source, ABSciex®) with a 50 µm internal diameter 
(ID) stainless steel emitter (NewObjective). 
The information dependent acquisition (IDA) experiments were performed for each pooled 
samples in two acquisitions per pool. The mass spectrometer was set to scanning full spectra 
(350-1250 m/z) for 250 ms, followed by up to 100 MS/MS scans (100–1500 m/z from a dynamic 
accumulation time – minimum 30 ms for precursor above the intensity threshold of 1000  – in 
order to maintain a cycle time of 3.3 s). Candidate ions with a charge state between +2 and +5 
and counts above a minimum threshold of 10 counts per second were isolated for fragmentation 
and one MS/MS spectra was collected before adding those ions to the exclusion list for 25 
seconds (mass spectrometer operated by Analyst® TF 1.7, ABSciex®). Rolling collision was 
used with a collision energy spread of 5. 
For SWATH-MS based experiments, the mass spectrometer was operated in a looped product 
ion mode (Gillet et al., 2012) and the same chromatographic conditions used as in the IDA run 
described above. A set of 60 windows (Table 1) of variable (width containing 1 m/z for the 
window overlap) was constructed covering the precursor mass range of 350-1250 m/z. A 250 ms 
survey scan (350-1500 m/z) was acquired at the beginning of each cycle for instrument 
calibration and SWATH MS/MS spectra were collected from 100–1500 m/z for 50 ms resulting 
in a cycle time of 3.25 s from the precursors ranging from 350 to 1250 m/z. The collision energy 
for each window was determined according to the calculation for a charge +2 ion centered upon 
the window with variable collision energy spread (CES) according with the window. 
A specific library of precursor masses and fragment ions was created by combining all files from 
the IDA experiments, and used for subsequent SWATH processing. 
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Table 1. SWATH-MS method. 
 
m/z range Width (Da) CES 
Window 1 349.5-360.9 11.4 5 
Window 2 359.9-375.2 15.3 5 
Window 3 374.2-389.2 15 5 
Window 4 388.2-402.2 14 5 
Window 5 401.2-415.3 14.1 5 
Window 6 414.3-427.4 13.1 5 
Window 7 426.4-439.1 12.7 5 
Window 8 438.1-449.9 11.8 5 
Window 9 448.9-460.7 11.8 5 
Window 10 459.7-471.1 11.4 5 
Window 11 470.1-480.5 10.4 5 
Window 12 479.5-490 10.5 5 
Window 13 489-499 10 5 
Window 14 498-508 10 5 
Window 15 507-516.5 9.5 5 
Window 16 515.5-525.1 9.6 5 
Window 17 524.1-533.2 9.1 5 
Window 18 532.2-540.8 8.6 5 
Window 19 539.8-548.5 8.7 5 
Window 20 547.5-555.7 8.2 5 
Window 21 554.7-563.4 8.7 5 
Window 22 562.4-570.6 8.2 5 
Window 23 569.6-577.8 8.2 5 
Window 24 576.8-585.4 8.6 5 
Window 25 584.4-592.6 8.2 5 
Window 26 591.6-600.3 8.7 5 
Window 27 599.3-607.9 8.6 5 
Window 28 606.9-615.6 8.7 5 
Window 29 614.6-623.2 8.6 5 
Window 30 622.2-630.9 8.7 5 
Window 31 629.9-638.5 8.6 5 
Window 32 637.5-646.2 8.7 5 
Window 33 645.2-653.8 8.6 5 
Window 34 652.8-661.5 8.7 5 
Window 35 660.5-669.1 8.6 5 
Window 36 668.1-677.2 9.1 5 
Window 37 676.2-685.3 9.1 5 
Window 38 684.3-693.9 9.6 5 
Window 39 692.9-702.9 10 5 
Window 40 701.9-711.9 10 5 
Window 41 710.9-721.3 10.4 5 
Window 42 720.3-731.2 10.9 5 
Window 43 730.2-741.6 11.4 5 
Window 44 740.6-752.4 11.8 5 
Window 45 751.4-763.6 12.2 5 
Window 46 762.6-775.8 13.2 5 
Window 47 774.8-787.9 13.1 5 
Window 48 786.9-800.5 13.6 5 
Window 49 799.5-814.5 15 8 
Window 50 813.5-829.3 15.8 8 
Window 51 828.3-845.5 17.2 8 
Window 52 844.5-865.3 20.8 8 
Window 53 864.3-886.5 22.2 8 
Window 54 885.5-911.2 25.7 8 
Window 55 910.2-939.1 28.9 8 
Window 56 938.1-972 33.9 8 
Window 57 971-1008.4 37.4 10 
Window 58 1007.4-1053.4 46 10 
Window 59 1052.4-1120 67.6 10 
Window 60 1119-1249.6 130.6 10 
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1.6. Database searches and quantification 
Libraries were obtained using Protein PilotTM software (v5.1, ABSciex®), using the following 
parameters: i) search against a database composed by all the entries for the species Meleagris 
gallopavo (https://www.ncbi.nlm.nih.gov/protein?LinkName=genome_protein&from_uid=112) 
which comprised 24245 non-redundant sequences and Gallus gallus 
(https://www.ncbi.nlm.nih.gov/protein?LinkName=genome_protein&from_uid=111) that 
comprised 41611 non-redundant sequences from NCBI (release at July 2016), and malE-GFP 
(IS); ii) iodoacetamide alkylated cysteines as fixed modification; iii) trypsin as digestion type. 
An independent False Discovery Rate (FDR) analysis using the target-decoy approach provided 
with Protein Pilot software was used to assess the quality of the identifications and positive 
identifications were considered when identified proteins and peptides reached a 5% local FDR 
(Sennels et al., 2009; Tang et al., 2008). 
Data processing was performed using SWATHTM processing plug-in for PeakViewTM (v2.0.01, 
ABSciex®) (Lambert et al., 2013). Briefly, peptides were selected automatically from the library 
using the following criteria: (i) the unique peptides for a specific targeted protein were ranked by 
the intensity of the precursor ion from the IDA analysis as estimated by the ProteinPilotTM 
software, and (ii) peptides that contained biological modifications and/or were shared between 
different protein entries/isoforms were excluded from selection. Up to 15 peptides were chosen 
per protein, and SWATHTM quantitation was attempted for all proteins in library file that were 
identified below 5% local FDR from ProteinPilotTM searches. In SWATHTM Acquisition data, 
peptides are confirmed by finding and scoring peak groups, which are a set of fragment ions for 
the peptide. 
Target fragment ions, up to 5, were automatically selected and peak groups were scored 
following the criteria described in Lambert et al. (2013). Peak group confidence threshold was 
determined based on a FDR analysis using the target-decoy approach and 1% extraction FDR 
threshold was used for all the analyses. Peptide that met the 1% FDR threshold in at least three 
of the four biological replicates were retained and the peak areas of the target fragment ions of 
those peptides were extracted across the experiments using an extracted-ion chromatogram 
(XIC) window of 4 minutes with 100 ppm XIC width.   
The levels of the proteins were estimated by summing all the transitions from all the peptides for 
a given protein that met the criteria described above (an adaptation of Collins et al., 2013) and 
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normalized to the total intensity of each sample. The internal standard (malE-GFP) was used to 
performed retention time alignment. 
 
1.7. Functional annotation and grouping 
The retrieved protein FASTA sequences were loaded on the open source online tool Blast2GO 
4.0.2 software (http://www.blast2go.com) which is a comprehensive high-throughput tool for 
gene ontology (GO) online tool. The default parameters were used and, for the basic local 
alignment search tool (BLAST), protein sequences were mapped against the NCBI database. The 
functional analysis was further narrowed by PANTHER classification 
(http://www.pantherdb.org). WEGO (http://wego.genomics.org.cn) has used to build graphics. 
Kyoto encyclopedia of genes and genomes (KEGG) database (released October 2016) was used 
to classify identified proteins into specific functional terms and metabolic pathways. 
 
1.8. Validation of proteomic results by qualitative PCR 
Qualitative PCR of selected genes, involved in immunity, inflammatory pathways and response 
to stimulus, was used to confirm protein expression data. Total RNA was extracted from the 
same tissue samples as those used for proteome analysis.  
RNA extraction was made using TriZol standard protocol (Invitrogen) and DNase treatment was 
carried out with DNase (Fermentas). RNA concentration and quality were validated as ratio 
A260/A280 by NanoDrop ND-1000 UV–vis spectrophotometer (NanoDrop Technologies Inc.). 
1 µg RNA was retrotranscribed using the iScript cDNA synthesis kit (Biorad). 
The resulting cDNA was amplified by means of a qualitative PCR, performed in 10 µL final 
volume containing 1x buffer (LeGene Biosciences), 1.5 mM MgCl2, 0.2 mM each 
deoxynucleotide triphosphate (dNTP), 1 µM each primer and 0.025 U Taq polymerase (LeGene 
Biosciences). PCR conditions were 35 cycles of 94ºC for 30 sec, 60ºC for 30 sec and 72ºC for 45 
sec (Eppendorf Mastercycler). PCR products were visualized on 1.6% agarose gel stained with 
ethidium bromide. 
Primers were designed on turkey sequences available in NCBI by using Primer 3 
(http://bioinfo.ut.ee/primer3-0.4.0), preventing possible secondary structures with the mfold Web 
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Server (http://mfold.rna.albany.edu/?q=mfold/DNA-Folding-Form) and ensuring the specificity 
of the sequence by Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo). Primer sequences 
and fragment sizes are described in Table 2. 
 
Table 2. List of the genes under study and their respective primers sequences, accession 
numbers and fragment lengths. 
Gene 
GenBank Primer Forward (5’-3’) Primer Reverse (5’-3’) 
Length 
(bp) 
PIT54 XM_003202017 GCCAGTGCAATTTGTTCAGA TCCCGTAAATCCCAGTTGTC 146 
SELENBP1 XM_010724013.1 AACCTGAAAGACGAGCTCCA AGATCAGGCATGGGAGAATG 103 
HPX XM_010706282.1 CTTCCAGGGTGAGAAGGTCTG CTCCTCAGGGTGACACTCCA 130 
ES1 XM_003208390.2 ACGTGAAAGGACAGCCAACT TCCAAAGCCACCTGGTATGA 137 
CORO2A XM_010726179.1 GTCCCTCGATGGTCAGAGTC GTCCAGAGCCTGGTCTCAAG 139 
FGB XM_003205349.2 TCAGGCAGAGAATGTGAGGA GGCTTGGTAAAAGGATCTGGC 86 
MPST XM_010711524.1 CAAGCCAGATGTTGCTGTGT TCCCAAATCCAGTTTCAAGG 156 
PGRMC1 NM_001271939.1 GAGGTCTTGCCACTTTCTGC TTCAGCAGCTTACCAACGTG 148 
CANX XM_003210435.2 ATGGAAACCCAGGAAGATCC CACAGCACTGAAGGGAGTCA 79 
IGLL1 XM_010720331.1 ACACCAACAGACCCTCGAAC CAGTGCTGCTGTCGTAGCTC 135 
PPIA NM_001166326.1 GTGCCCATAACAGCAGAGAAC ACCACCCTGACACATGAAGC 111 
GPA33 XM_010721705.1 ATGACAGTCAGCGTTGTCCC TTCTCTTGCCGTCTCCTCGT 150 
CALM NM_205005.1 ACTTGGTCAGAACCCCACAG TCAATTGTGCCATTGCCATCAG 78 
SDSL XM_010720582.1 GCCAAGACTGTGTCAGAACG TCATCCAGGAACCTTTCCAC 110 
BDH2 XM_003205765.2 AATCTAACCCAGACCAGGCAC CCACTTCTTCAGCGGTAGCC 78 
PIT54, scavenger receptor cysteine-rich domain-containing protein LOC284297 homolog (haptoglobin-like); SELENBP1, 
selenium-binding protein 1-A; HPX, hemopexin; ES1, ES1 protein homolog; CORO2A, coronin-2A; FGB, fibrinogen beta 
chain; MPST, 3-mercaptopyruvate sulfurtransferase; PGRMC1, membrane-associated progesterone receptor component; 
CANX, calnexin; IGLL1, immunoglobulin lambda-like polypeptide 1; PPIA, peptidyl-prolyl cis-trans isomerase A; GPA33, 
cell surface A33 antigen; CALM, calmodulin; SDSL, serine dehydratase; BDH2, 3-hydroxybutyrate dehydrogenase type 2. 
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1.9. Statistical analysis 
Data analysis was conducted with principal component analysis (PCA) and partial least squares 
discriminant analysis (PLS-DA) using SIMCA P software package (Umetrics) in order to 
observe intrinsic clusters and obvious outliers (based on the principles of Hotelling T2) within 
the data set. Student t-test, with a two-tailed distribution and an homoscedastic variance was 
used for all statistical analyses. Significance accepted for p-values ≤ 0.05. 
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2. Results and discussion 
 
In order to study protein expression characteristics of turkey intestine, we carried out a proteome 
mapping of intestinal mucosa collected from healthy and HEV-infected animals. Protein target 
database resources of turkey are still incomplete and poorly annotated. To compensate, we have 
combined two databases, turkey and chicken, composed by nonredundant proteins from NCBI 
database (version of July 2016) to boost the number of identified proteins. 
Using SWATH-MS strategy, a library was created with 7013 identified peptides, corresponding 
to 929 different proteins. After filtering for proteins which were quantified in at least three of 
four biological replicates and with at least one peptide (FDR = 1% and a confidence of 99%), 
this library allowed the quantification of 523 proteins among eight samples, which were included 
in this comparative and descriptive analysis (Supplementary Table 1). 
 
2.1. Functional grouping of intestinal mucosa proteome 
From our dataset composed by 523 proteins, only 185 protein number identifiers were 
successfully mapped on UniProtKB website (http://www.uniprot.org) and 45 were mapped on 
PANTHER website (http://www.pantherdb.org). Since more than 60% of the UniProtKB 
proteins were lacking and/or were classified as “Uncharacterized protein”, we ran BLAST using 
Blast2GO software (https://www.blast2go.com) to annotate our protein dataset.  
Gene Ontology (GO) analysis was performed using the three main ontologies (Cellular 
Component, Molecular Function and Biological Process). Blast2GO retrieved 841 unique 
Biological Process GO terms, 541 unique Molecular Function GO terms and 800 unique Cellular 
Component GO terms associated with our dataset. From 523 total proteins, 18 sequences were 
not annotated. For a clearer representation, graphics were designed using WEGO website 
(http://wego.genomics.org.cn) (Figure 1). 
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Figure 1. Proteome characteristics of mucosa intestine. GO classification using Blast2GO shows level 2 
categories for Cellular Components, Molecular Function and Biological Processes. 
 
523 proteins were grouped into 28 GO terms divide into three ontologies:  
Cellular component: 40.6% cell, 40.6% cell part, 31.3% organelle, 23.4% macromolecular 
complex, 17.2% organelle part, 10.9% extracellular region, 10.9% extracellular region part, 7.8% 
membrane-enclosed lumen and 4.7% envelope. 
Molecular function: 57.8% binding, 39.1% catalytic activity, 9.4% structural molecule activity, 
3.1% transporter activity, 1.6% electron carrier activity, 1.6% molecular transducer activity and 
1.6% transcription regulator activity. 
Biological process: 42.2% metabolic process, 42.2% cellular process, 9.4% cellular component 
biogenesis, 7.8% biological regulation, 6.3% cellular component organization, 6.3% localization, 
4.7% pigmentation, 3.1% anatomical structure formation, 1.6% biological adhesion, 1.6% 
biological process, 1.6% multicellular organismal process and 1.6% response to stimulus. 
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2.2. Data Analysis 
Due to the large amount of data generated in proteomics studies and its complexity, multivariate 
methods could be applied, such as principal component analysis (PCA) and partial least squares 
discriminant analysis (PLS-DA), allowing identification of proteins that can explain the 
differences we observed. 
PCA is a powerful statistical tool/analysis that finds the most important trends in a dataset. Each 
sample is represented by a point in a score-plot, being classified as a member of one class if they 
fall within its boundaries. Samples which lie close to each other in the score-plots have similar 
profiles, whereas samples which lie far apart are very different and are classified as a member of 
a different class. In the other side, PLS-DA is a more powerful technique for discriminating 
between classes previously established, in our case, healthy and sick animals. Similar to PCA, it 
works by calculating a multivariate projection of the data and maximises the separation of the 
classes. 
PCA and PLS-DA were applied to the 523 proteins quantified as multivariate statistical method. 
Based on the principles of Hotelling T2 (95% confidence limit), four healthy animals and four 
disease-affected animals were separated into two groups (Figure 2). In PCA score-plot, we can 
see a disperse pattern for all samples (Figure 2A). However, HEV-affected samples tends to stay 
in the right panel whereas healthy samples aggregates itself in the middle. Since we already 
know the samples that compose our two groups and, after perform a PLS-DA, a more powerful 
separation was obtained and both groups were separated completely (Figure 2B). Healthy 
samples are on the left side, whereas HEV-affected samples stayed on the right side of score-
plot, perfectly divided in two groups. This suggest that from our list of proteins, some of them, 
when combined together, allow us to distinguish clearly healthy animals from HEV-affected 
animals. 
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Among all differentially expressed proteins, S-adenosylmethionine synthase isoform type-2-like 
isoform X2 (LOC427292), trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (DHDH), 
selenium-binding protein 1-A isoform X2 (SELENBP1), ATP synthase subunit f mitochondrial 
(ATP5J2), glycerol kinase isoform X4 (GK), NADH dehydrogenase [ubiquinone] 1 beta 
subcomplex subunit 10 (NDUFB10), fibrinogen beta chain (FGB) and tropomyosin alpha-1 
chain isoform X16 (TPM1) had the meaningful changes. 
 
Sixty-four proteins of differential abundance were grouped into nine classes based on their 
putative functions: amino acid and protein metabolism (25%), carbohydrate metabolism (19%), 
fatty acids metabolism (16%), cytoskeleton (11%), immune system (11%), nucleic acid 
biogenesis (6%), ribosome (6%), binding and transport (5%) and apoptosis (1%) (Figure 4). 
 
 
Figure 4. Functional classification of the proteins of differential abundance identified from the intestinal 
mucosa of turkey. 
 
Those related to amino acid and protein metabolism, carbohydrate metabolism, fatty acids 
metabolism, cytoskeleton and immune system were predominant and accounted for 
approximately 80% of the differential proteins. 
A comparison of proteins differential abundant between both groups showed that 49 proteins 
were up-regulated and 15 down-regulated in HEV-affected animals (Figure 5). 
 
25%
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Carbohydrate metabolism
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Immune system
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The 49 up-regulated proteins were distributed in ten classes: 13 in amino acid and protein 
metabolism, 9 in carbohydrate metabolism, 7 in fatty acids metabolism, 7 in immune system, 4 
in nucleic acid biogenesis, 4 in ribosome, 3 in cytoskeleton, 1 in binding and transport and 1 in 
apoptosis.  
The 15 down-regulated protein were distributed in six classes: 4 in cytoskeleton, 3 in amino acid 
and protein metabolism, 3 in carbohydrate metabolism, 3 in fatty acids metabolism and 2 in 
binding and transport. 
 
 
Figure 5. Quantitative analysis of the proteins of differential abundance from HEV-affected intestinal 
mucosa. 
 
2.4. mRNA expression of selected proteins related with immune system 
The intestine is crossed by a wide capillary network. The finding of a protein by proteomic 
techniques does not confirm its expression by intestine. Several proteins can be expressed by 
liver or other tissues and then delivered to intestine through blood. Therefore, the effective 
presence of proteins related with immune response on intestinal mucosa was confirmed by 
qualitative PCR through detection of their respective mRNAs.  
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Fifteen proteins (selenium-binding protein 1-A (SELENBP1), hemopexin (HPX), PIT54, 
fibrinogen beta chain (FGB), membrane-associated progesterone receptor component 
(PGRMC1), immunoglobulin lambda-like polypeptide 1 (IGLL1) and cell surface A33 antigen 
(GPA33) grouped into immune system classe; ES1 protein homolog (ES1), coronin-2A 
(CORO2A), 3-mercaptopyruvate sulfurtransferase (MPST), calnexin (CANX), peptidyl-prolyl 
cis-trans isomerase A (PPIA) and calmodulin (CALM) related with inflammation, viral and 
bacterial defenses and response to external stimulus; and serine dehydratase (SDSL) and 3-
hydroxybutyrate dehydrogenase type 2 (BDH2) up-regulated more than 2 times in healthy 
mucosa) were selected for functional validation at RNA level using qualitative PCR. No studies 
have investigated their mRNA expression in turkey intestine to date. Results are summarized in 
Table 4 and pictures of the agarose gel electrophoresis can be seen in Figure 6. Liver was also 
included in this analysis as an internal control.  
Thirteen and 11 genes out of 15 were found expressed by HEV-affected and healthy mucosa, 
respectively. Four genes out of 15 were not found expressed by intestinal mucosa of healthy 
animals, suggesting that these proteins are delivered to intestine through blood in a normal state. 
These include selenium-binding protein 1-A (SELENBP1), hemopexin (HPX) and fibrinogen 
beta chain (FGB). Interesting, mRNA of these genes, except HPX, was detected in intestinal 
mucosa affected with HEV. HPX mRNA was undetectable in intestinal mucosa of HEV-affected 
animals, suggesting that intestine cannot produce this protein and it needs to be delivered via 
blood capillaries. ES1 protein homolog (ES1) was not detected either in liver nor intestine. We 
cannot rule out the hypothesis that primers are not working since liver was negative and another 
positive control was not included. 
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Table 4. mRNA expression of inflammation and innate immunity-related proteins in turkey 
intestinal mucosa. Qualitative PCR results: P, presence; A, absence. 
Gene name Liver 
Healthy 
intestinal mucosa 
HEV-affected 
intestinal mucosa 
SELENBP1, selenium-binding protein 1-A P A P 
HPX, hemopexin P A A 
PIT54, haptoglobin-like P P P 
FGB, fibrinogen beta chain P A P 
PGRMC1, membrane-associated progesterone receptor P P P 
IGLL1, immunoglobulin lambda-like polypeptide 1 P P P 
GPA33, cell surface A33 antigen A P P 
ES1, ES1 protein homolog A A A 
CORO2A, coronin-2A A P P 
MPST, 3-mercaptopyruvate sulfurtransferase P P P 
CANX, calnexin P P P 
PPIA, peptidyl-prolyl cis-trans isomerase A P P P 
CALM, calmodulin P P P 
SDSL, serine dehydratase P P P 
BDH2, 3-hydroxybutyrate dehydrogenase type 2 P P P 
 
  
 Figure 6. PCR amplification pro
CORO2A, GPA33, CANX, ES1, 
intestinal mucosa mRNA separate
Non-template reaction was used as
ducts of PIT54, SDSL, IGLL1, PGRMC1, SE
BDH2, MPST, PPIA and CALM in liver, heal
d by agarose gel electrophoresis (1.6%) stained w
 negative control. 
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LENBP1, HPX, FGB, 
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ith ethidium bromide. 
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The presence of FGB in turkey HEV-intestine confirms previous studies in chicken infected with 
gastrointestinal diseases (Georgieva et al., 2010). Fibrinogen is a glycoprotein synthetized by 
hepatocytes and considered an APP in chicken. The RNA expression of SELENBP1 by intestine 
in poultry has never been investigated, but SELENBP1 has been observed in several types of 
human cancers, including colorectal cancer (Kim et al., 2006). SELENBP1 is a member of 
selenium-binding protein family, which have been shown to bind selenium covalently (Porat et 
al., 2000). SELENBP1 role in intestine is not known, however SELENBP1 is a target of 
hypoxia-inducible factor-1α to respond to reactive oxygen species (ROS) (Huang et al., 2012) 
and it is associated with alterations of lipid/glucose metabolism-related proteins (Ying et al., 
2015). Also mRNA presence of PGRMC1 has never been described in intestine. PGRMC1 is a 
single transmembrane protein that forms part of a multi-protein complex that binds to 
progesterone and other steroids, and it is associated with cancer in humans (Cahill, 2007). There 
is evidence that progesterone modulates immune function in mammals (Dosiou et al., 2008) and 
promotes T cell differentiation (Piccinni et al., 1995).  
Intestine is regarded as one essential organ for nutrient absorption, pathogen prevention and 
immune response (Furness et al., 1999; Lillehoj and Trout, 1999), established interaction 
between different microbial species and contributing to the animal welfare. The important role of 
intestinal mucosa in the immune response is demonstrated by the RNA expression of acute phase 
proteins and genes related with B-lymphocytes differentiation and epithelial mucosa integrity, 
namely PIT54, IGLL1 and GPA33. PIT54 is homologous to haptoglobin in mammals and has 
been identified as the major hemoglobin-binding protein in birds (Quaye, 2008; Wicher and 
Fries, 2006). As already described before, PIT54 is considered one APP in poultry and its 
extrahepatic expression is described in this thesis. The IGLL1 gene encodes a component of the 
pre-B-cell receptor, which is crucial for B cells development (Chen et al., 2016). Zandi et al. 
(2012) have also found IGLL1 gene expressed in cattle fetal tissues, including intestine, however 
its expression by avian intestine has never been reported. The malfunction of the epithelial cells 
caused by HEV can be demonstred by the expression of GPA33, a gene identified in human and 
mice intestine, and overexpressed in many tumors (Johnstone et al., 2002; Solmi et al., 2004). 
GPA33 is an intestinal epithelium-specific cell surface marker and a component of the tight 
junction-associated proteins of the immunoglobulin superfamily (Ackerman et al., 2008; 
Johnstone et al., 2000) and it is involved in immune signalling (Mallegol et al., 2007; Van Niel et 
al., 2003). GPA33 is also crucial for the maintenance of intestinal barrier function (Williams et 
al., 2015). We did not detect GPA33 expression in liver and, in fact, literature refers its 
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expression only in intestine. Interestingly, HPX mRNA was not found, although its protein has 
been increased by 2.5-folds in HEV-affected intestine. HPX is considered another APP induced 
by inflammation in chicken (Adler et al., 2001). Takagi et al. (2012) have also reported the 
presence of HPX protein in injured intestinal mucosa of rats, but not at mRNA level. HPX has 
the highest binding affinity to heme group, sequestering heme from pathogens and protecting 
cells against toxicity (Dooley et al., 2010; Tolosano and Altruda, 2002), suggesting the 
importance of this protein to be translocated into intestine by blood. 
Other proteins that have been identified by proteomics and validated by gene expression studies 
include CORO2A, MPST, CANX, PPIA, CALM, ES1, SDSL and BDH2. Although these 
proteins were not classified as immune system-involved, after a bibliographic search, we found 
them associated with innate immunity, inflammation, viral and bacterial responses and external 
stimulus. Coronin proteins are known as regulators of actin-based cellular processes, and 
CORO2A is associated with human colon carcinoma (Rastetter et al., 2005). Huang et al. (2011) 
have shown evidence that CORO2A controls inflammatory response and is required for de-
repression of TLR target genes by macrophages. CORO2A expression by liver has also not been 
reported yet. CANX is an important chaperone of the endoplasmic reticulum and is involved in 
secretory pathways. Its involvement in innate immunity and intestinal paneth cells’ 
differentiation have already been reported (Gassler et al., 2002; Huang et al., 2016). PPIA (or 
better known as Cyclophilin A) is reported in literature in association with viral infections in 
chicken, such as Influenza Virus and Infectious Bursal Disease Virus (Frausto et al., 2013; Wang 
et al., 2015; Xu et al., 2010), and heat intestinal stress in pigs (Pearce et al., 2015). Moreover, it 
has been reported that CypA is involved in T cell activation and in the IFN-I or IL-2 responses 
during virus infections (Dawar et al., 2016; Rauf et al., 2011).  
MPST is another protein, which gene we found in intestine. Although not directly involved with 
immune system, MPST can help with reactive oxygen species (ROS) higher levels generated 
during haemorrhagic shock and playing an important role in cyanide detoxification, avoiding in 
this way the significant damage to cell structures (Iciek et al., 2005). CALM is a multifunctional 
calcium sensor protein that participates in various immune functions such as programmed cell 
death, autophagy, inflammation and the immune response (Tidow and Nissen, 2013). We found 
CALM protein more expressed by HEV-affected intestine and the presence of its mRNA was 
also validated. Consistent with our findings, Connell et al. (2013) found the same gene 
associated with avian colonization by Campylobacter jejuni in chicken, suggesting the 
importance of the calcium absorption in the maintenance of intestinal homeostasis. 
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ES1 gene was also included in this analysis. ES1 protein homolog mRNA was induced in 
intestine of chickens infected with Salmonella enterica (Matulova et al., 2013; Rychlik et al., 
2014). However, in our study the mRNA was undetected in any samples included, then we have 
to consider the possibility that our designed primers did not work. 
Finally, SDSL and BDH2 are two proteins involved in protein and fatty acid metabolism, 
respectively, which folds were 2-times increased in healthy animals. Therefore, its mRNA 
expression was investigated. Both mRNA were found in healthy and sick intestine. It is 
notorious that serine dehydratase members have already been reported in the colonization of the 
avian gut by C. jejuni (Velayudhan et al., 2004), whereas we found it more expressed by healthy 
birds. No previous studies have investigated BDH2 expression in chicken intestinal mucosa and 
validated by mRNA expression. Inflammation of the gastrointestinal tract generates a stressful 
condition, which can lead to a intestine shutdown and decreases enzymes and secretions needed 
for digestion. A normal metabolism is occuring in the healthy birds, while the need for digestion 
enzymes was stopped in affected animals.  
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3. Conclusions 
 
It has become increasingly clear that intestine plays important roles in a wide range of biological 
processes, including metabolic control, oxidative stress, inflammation, as well as for both innate 
and adaptive immune response in poultry. However, depth knowledge of the biochemistry and 
molecular characteristics of intestinal mucosa has not yet properly been addressed so far. 
To the best of our knowledge, we have here presented the first comparison of healthy and HEV-
affected intestinal mucosa proteomes in turkey. The analysis was carried out by SWATH-MS 
strategy and the global proteome mapping allowed the identification of 523 proteins, being 64 
differentially expressed. HEV disease induced changes in a higher number of proteins related 
with protein, carbohydrate and lipid processes, and immune system. Furthermore, the validation 
at gene expression level of proteins involved in inflammation, infection and immune response 
demonstrated that intestine expresses, at least, 13 genes involved in these mechanisms. Little is 
so far known about the intestinal immunity in turkey species, although it is of key importance for 
the management of animal health and also for economic gain.  
Further research is needed to investigate if the quantitative protein results found by proteomic 
technique is consistent with quantitative gene expression. Quantitative Real Time PCR will be 
done to quantify the fifteen genes validated by qualitative PCR. 
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5.5. Acute phase proteins mRNA changes in the liver, adipose tissue 
and jejunum of turkeys (Meleagris gallopavo) infected with 
haemorrhagic enteritis virus 
 
 
Results presented here are still preliminary and required further studies before they can be 
published. 
 
 
Keywords: acute phase proteins, animal welfare, haemorrhagic enteritis virus, intestine, 
Meleagris gallopavo. 
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Abstract 
 
The aim of this study was to investigate how four acute phase proteins (APPs), namely α1-acid 
glycoprotein (AGP), Serum Amyloid A (SAA), PIT54 and C-Reactive Protein (CRP), can be 
modified by a disease in turkey (Meleagris gallopavo). Heamorrhagic enteritis (HE) is a stressful 
disease in turkeys, caused by an adenovirus. HE disease is characterized by acute onset of 
depression, splenomegaly, intestinal haemorrhage and sudden death. Surviving birds exhibit 
HEV-induced immunosuppression condition, which facilitates secondary infections with 
opportunistic pathogens agents such as the avian pathogenic Escherichia coli, resulting in 
significant economic loss. A group of five BUT BIG 6 commercial hens infected with HE virus, 
which presented lesions at jejunum level, were included in this study and the quantitative gene 
expression of APPs in the liver, adipose tissue and jejunum was compared to that of healthy 
control group, composed by nine birds. The expression of AGP, PIT54 and SAA was found to be 
increased in sick animals. AGP and SAA mRNA expression were increased in both liver and 
adipose tissue, whereas PIT54 mRNA expression was increased in liver alone. CRP mRNA 
expression was decreased in HEV-infected birds. The results of this study are still preliminary 
but they show that HE disease affects APPs expression. The finding that AGP, PIT54 and SAA 
are upregulated in sick animals validates their use as welfare biomarkers in turkey. 
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1. Material and methods 
 
1.1. Samples collection and preservation 
Liver, visceral adipose tissue and jejunum samples were collected during routinely slaughtering 
procedures from nine 92 day-old clinically healthy BUT BIG 6 breeding line female turkeys and 
five BUT BIG 6 breeding line female turkeys PCR HEV positive (HEV-infected animals) and 
with lesions in intestine at jejunum level. Clinical status of the animals was also assessed by 
ante- and post-mortem inspection. Portions of liver, visceral adipose tissue and jejunum were 
removed immediately after slaughtering, snap frozen into liquid nitrogen and afterwards stored at 
−80ºC (for gene expression analyses).  
 
1.2. Qualitative and quantitative mRNA expression 
Total RNA was extracted using QIAzol lysis reagent according to the manufacturer’s protocol 
(Qiagen) and treated with DNase I (Thermo Fisher Scientific, Fermentas). Total RNA was 
quantified using a NanoDrop ND-1000 UV–vis spectrophotometer. Reverse transcription was 
carried out with 1 µg RNA using the iScript cDNA Synthesis Kit (BioRad). The cDNA was used 
as template for PCRs. 
Qualitative PCR was performed in 10 µL final volume containing 1x buffer, 1.5 mM MgCl2, 0.2 
mM each deoxynucleotide triphosphate (dNTP), 1 µM each primer and 0.025 U Taq polymerase 
(LeGene Biosciences). PCR conditions were 35 cycles of 94ºC for 30 sec, 60ºC for 30 sec and 
72ºC for 45 sec (Eppendorf Mastercycler). PCR products were visualized on 1.6% agarose gel 
stained with ethidium bromide. The same primers were used in qualitative and quantitative PCR 
(Table 1). 
Quantitative real time PCR (qPCR) was performed using 12 µL Eva Green Supermix (BioRad), 
250 nM AGP and PIT54, 300 nM SAA and CRP and 400 nM GAPDH, YWHAZ and RPL4, 
using Eco Real-Time PCR System (Illumina). In order to evaluate the PCR efficiency using a 
relative standard curve, series of dilution were prepared by performing fourfold serial dilution 
starting from the pooled sample composed by a liver cDNA mix from five healthy animals. Each 
sample was tested in duplicate. Non-reverse transcribed controls were performed by omitting 
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reverse transcription and no template controls were conducted by adding nuclease free water. 
The thermal profile used (95°C for 10 min, 40 cycles of 95°C for 10 sec and 60°C for 30 sec; for 
melting curve construction, 55°C for 15 sec and 80 cycles starting to 55°C and increasing 0.5°C 
each 10 sec) was the same for each target gene. The MIQE guidelines were followed (Bustin et 
al., 2009). For all genes studied, the standard curves derived from serial dilution of pooled 
sample gave correlation coefficients (R2) greater than 0.990 and efficiencies greater than 94%. 
Results were compared using the comparative ∆-∆Cq method. 
 
Table 1. List of the genes under study and their respective primers sequences, accession 
numbers and fragment lengths. 
Gene GenBank Primer Forward (5’-3’) Primer Reverse (5’-3’) 
Length 
(bp) 
AGP XM_003211214 TCCCTGCCGAAATAGACAAC TCCTTCATCTCAGCCATGTG 103 
SAA XM_003206257.1 TGCTTCGTGTTGCTCTCCAT CATGTCCCGGTATGCTCTCC 123 
PIT54 XM_003202017 GCCAGTGCAATTTGTTCAGA TCCCGTAAATCCCAGTTGTC 146 
CRP EU106581.1 ATCCCATGCTCAACTTCACC CCGACGTAGAAGCGGTACTC 145 
GAPDH GQ184819.1 GATCCCTTCATCGACCTGAA ACAGTGCCCTTGAAGTGTCC 77 
RPL4 XM_003209573.1 TGTTTGCCCCAACCAAGACT TCCTCAATGCGGTGACCTTT 136 
YWHAZ XM_003205203.1 TTCCCTTGCAAAAACGGCTT TTCAGCTTCGTCTCCTTGGG 148 
AGP, alpha 1-acid glycoprotein; SAA, serum amyloid A; PIT54, scavenger receptor cysteine-rich domain-containing 
protein LOC284297 homolog (haptoglobin-like); CRP, C-reactive protein; GAPDH, glyceraldehyde 3-phosphate 
dehydrogenase; RPL4, ribosomal protein L4; YWHAZ, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein, zeta.SAA, PIT54, CRP, GAPDH, RPL4 and YWHAZ were from Marques et al. (2016). AGP and 
OVT primers were designed using Primer 3 (http://bioinfo.ut.ee/primer3-0.4.0). 
 
1.3. Statistical analysis 
Statistical analysis was performed using a General Linear Model procedure of SAS (SAS version 
9.2 Inst. Inc., Cary, NC). Least significant difference was used to compare mean values. 
Statistical significance was accepted at p-value ≤ 0.05. 
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2. Results 
 
2.1. HEV influences mRNA abundance of AGP, PIT54 and SAA in liver 
APP mRNA abundance in liver from healthy and HEV-infected animals was determined by 
qPCR after normalization against reference genes. Results are presented in Figure 1. Liver AGP, 
PIT54 and SAA mRNA abundance was found to be statistically significantly increased sick 
animals (HEV-infected), as compared with healthy animals (p-value = 0.0438, 0.0232 and 
0.0071, respectively). The mRNA abundance of CRP did not show any statistical significant 
difference. 
 
 
Figure 1. Relative expression of AGP, PIT54, SAA and CRP in liver of healthy and HEV-infected 
turkeys studied by qPCR. The results were normalized using the geometric mean of reference genes 
(GAPDH, YWHAZ and RPL4). Data are means ± SEM of five HEV-infected and nine healthy animals. 
Folds relative to liver=1. 
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2.2. HEV influences mRNA abundance of AGP, PIT54 and SAA in adipose tissue 
APP mRNA abundance in adipose tissue from healthy and HEV-infected animals was 
determined by qPCR after normalization against reference genes. Results are presented in Figure 
2. Adipose tissue AGP and SAA mRNA abundance was found to be statistically significantly 
increased sick animals (HEV-infected), as compared with healthy animals (p-value = 0.0071 and 
0.0016, respectively). The mRNA abundance of PIT54 and CRP did not show any statistical 
significant difference. 
 
 
Figure 2. Relative expression of AGP, PIT54, SAA and CRP in adipose tissue of healthy and HEV-
infected turkeys studied by qPCR. The results were normalized using the geometric mean of reference 
genes (GAPDH, YWHAZ and RPL4). Data are means ± SEM of five HEV-infected and nine healthy 
animals. Folds relative to liver=1. 
 
2.3. HEV influences mRNA abundance of AGP, PIT54 and SAA in jejunum 
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compared with HEV-infected animals (p-value = 0.0159). The mRNA abundance of AGP, PIT54 
and SAA did not show any statistical significant difference. 
 
 
Figure 3. Relative expression of AGP, PIT54, SAA and CRP in jejunum of healthy and HEV-infected 
turkeys studied by qPCR. The results were normalized using the geometric mean of reference genes 
(GAPDH, YWHAZ and RPL4). Data are means ± SEM of five HEV-infected and nine healthy animals. 
Folds relative to liver=1. 
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3. Discussion 
 
Although HEV related diseases have been known for many years, this is the first study 
demonstrating that APPs are more expressed in liver, adipose tissue and jejunum of HEV-
infected turkeys, at least at mRNA expression. We found that the HEV infection modifies liver 
mRNA abundance of AGP, SAA and PIT54. Remarkably, adipose tissue was also found to be 
reactive to HEV disease, since AGP and SAA mRNA abundance was found also increased in 
sick animals. 
AGP is one of the most widely measured APP in chicken (O'Reilly and Eckersall, 2014) and its 
role as APP in turkey have been demonstrated in this thesis and literature (Marques et al., 2016). 
In agreement with our results, elevated serum AGP levels have already been observed in 
chickens infected with viral pathogens (Inoue et al., 1997; Jang et al., 2013; Nakamura et al., 
1996). AGP plays important anti-inflammatory and immunomodulatory roles to control 
inflammation (Luo et al., 2015) and its immunomodulatory activity is focused on dampening the 
side effects of inflammation, including inhibition of phagocytosis and monocyte apoptosis 
(Ceciliani et al., 2007; Lecchi et al., 2013). Although HEV disease is caused by an adenovirus, it 
has been proposed that the lesions in the intestinal epithelial cells is not due to the effects of the 
virus but, instead, due to an exacerbating cytokine-mediated reaction (Suresh and Sharma, 1996). 
Given that AGP mRNA was found to be statistically significantly overexpressed in both liver 
and adipose tissue, we speculate that the higher amount of AGP in HEV-infected animals is 
modulating the negative effects of the inflammation. 
PIT54 is homologous to the mammalian haptoglobin – a hemoglobin-binding protein (Quaye, 
2008; Wicher and Fries, 2006). PIT54 mRNA abundance was found to be increased only in liver 
and not in adipose tissue. Interestingly, we found in our previous work that PIT54 was 
overexpressed in adipose tissue in response to transport-induced stress. The role of PIT54 in 
adipose tissue still deserves further investigation. Under a HEV pathological condition, 
hemoglobin may leak into the blood in high concentrations that are toxic for the surrounding 
tissues. This hemoglobin can be sequestered by PIT54, inhibiting its oxidative activity (Nielsen 
and Moestrup, 2009). PIT54 has been recently associated with avian infectious bronchitis virus 
(IBV) infection (Asasi et al., 2013). 
Among the other APPs included in the present study, SAA was the one that has shown the 
highest overexpression in HEV-infected animals as compared with control (9-folds higher in 
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liver and 4.5-folds higher in adipose tissue). SAA is a major APP in vertebrates and can easily 
increase its concentration up to 1000–fold as response to a disease. SAA belongs to a family of 
apolipoproteins, which are rapidly released into blood circulation when they are associated with 
high-density lipoprotein (HDL) (Benditt and Eriksen, 1977). SAA may serve as an immune 
opsonin for bacteria (Shah et al., 2006), and not only induces the expression of pro-inflammatory 
cytokines but also those exhibiting anti-inflammatory properties, such as IL-1 and IL-10 (Cheng 
et al., 2008; Ye and Sun, 2015). Supporting our results, SAA levels were also found as increased 
in chickens infected with IBV (Asasi et al., 2013). The finding that adipose tissue can express 
SAA is not new (Ceciliani et al., 2015), but it was found for the first time in turkey in the present 
investigation. SAA has been regarded as an adipokine and regulates the adipocyte cholesterol 
efflux (Poitou et al., 2009). 
CRP mRNA abundance was not modified in liver and adipose tissue from sick animals. 
However, other studies have identified CRP increment in response to bacteria and viral 
infections in chicken (Patterson and Mora, 1964; Rauber et al., 2014; Seifi et al., 2014). 
Interestingly, CRP mRNA expression was statistically higher in jejunum from healthy animals. 
The results presented here are still preliminary and more studies and experimental conditions are 
required before we can conclude that CRP is a negative APP for HEV disease model. CRP has 
never been described as a negative APP in poultry. Nevertheless, it would not be the first 
description that one of the major APP for many species was described as negative APP. For 
example, AGP has recently identified as a negative APP in pigs (Heegaard et al., 2013). 
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4. Conclusions 
 
In conclusion, the present study provides information on acute phase proteins behaviour during a 
disease model in turkey. On the background of mRNA abundance data, the concentration of 
AGP, PIT54 and SAA might be modified in liver and adipose tissue from turkeys infected with 
heamorrhagic enteritis virus, while CRP mRNA was decreased in jejunum. Although 
encouraging, these results must be considered as preliminary. More animals need to be included 
and the study must be paralleled by the measurement in serum of the respective transcript 
product, in order to confirm that AGP, PIT54 and SAA proteins are overexpressed in sick birds. 
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Chapter 6. Final remarks and conclusions 
 
Poultry is one of the most consumed meat in the world. Stress and diseases play important 
biological roles, not only for animal health, but also for quality and gain in meat. A specific 
knowledge of methods to assess poultry welfare is of key importance for the management of 
animal well-being and thereby also for economic income and meat quantity and quality. Welfare 
biomarkers are of great help in understanding the physiological and molecular state of the birds. 
The aims of this thesis was to identify the major acute phase proteins in turkey species, which 
have never been addressed until now, and characterized their expression using a stress model by 
road transport, one of the most stressful events in birds’ life. Following the identification of 
welfare biomarkers, we have also studied the novel microRNAs as emergent biomarkers in other 
species but never addressed in turkey species. We have characterized their expression using the 
same stress model by road transport. Liver is the main organ to produce acute phase proteins, 
however extrahepatic expression have been described in many species. In poultry, this 
description has been poorly addressed, and we have studied for the first time the extrahepatic 
expression of five very well known APP in 20 chicken tissues under non-pathological condition. 
Moreover, turkey intestinal mucosa was determined by proteomic techniques and the local 
expression for some genes related with immune system was described. Gastrointestinal tract is 
regarded as one of the most important organ for poultry welfare. 
With the experiments presented in this thesis, we have identified for the first time four APPs in 
turkey species – AGP, SAA, PIT54 and CRP – and demonstrated that they are involved with 
stress by road transport procedures and stress by heamorrhagic enteritis infection, which 
decrease the animals’ welfare. AGP, CRP and PIT54 mRNA expression was related to stress, 
while AGP, PIT54 and SAA mRNA expression was related to disease in turkey. In addition, 
microRNAs involvement in stress-related procedures was also described for the first time in 
turkey species and three miRNAs – miR-22, miR-155 and miR-365 – were acknowledged was 
possible welfare biomarkers. The diagnostic value of these candidate miRNAs was confirmed by 
ROC curve. 
It is known that APP can be found in extrahepatic tissues. We have described for the first time 
that 20 tissues in chicken can produce APP, even without any association with inflammation or 
diseases, contributing in this way for the local surveillance and immunity. The mRNA coding for 
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five APP – AGP, SAA, PIT54, CRP and OVT – was detected in our panel of tissues with a 
higher expression in gastrointestinal tract, respiratory system and lymphatic system. 
Furthermore, we hereby presented the first proteomic study on turkey intestinal mucosa healthy 
and infected with haemorrhagic enteritis virus. The global proteome mapping allowed the 
identification of 523 unique proteins. In this thesis, we demonstrated that turkey intestine 
produce at least 64 proteins differentially expressed and involved in amino acid and protein 
metabolism, carbohydrate metabolism, fatty acids metabolism, cytoskeleton, immune system, 
nucleic acid biogenesis, ribosome, binding and transport and apoptosis, confirming the 
involvement of intestinal mucosa in these processes. 
Since intestine has an intense capillary network, proteins can be produced by other organs and 
carried to intestine through blood. In addition, we demonstrated the expression by intestine of 11 
proteins involved in inflammatory and immune processes, providing further insight in the 
immunological competence of intestine. However, little is so far known about these molecular 
mechanisms and further investigation are of great interest, also from an economical point of 
view. 
In conclusion, this thesis provided information about biomarkers of stress in poultry. Beside the 
obvious implementation of the results of this study in the field of biomarkers, further 
investigations are required, in particular for what concerns the pathways regulated by miRNA in 
the specific activation of hypotahalamic-pituitary-adrenal axis and how it is its impact on the 
regulation of the innate immunity in poultry species.  
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